HONOR. HOMEOSTASIS. HOPE.
Library
(Under Construction: Sharing does not reflect endorsement or the degree of accuracy of opinions reflected in resources.
Cadherins and Usher Syndrome
Astuto, L. M., Bork, J. M., Weston, M. D., Askew, J. W., Fields, R. R., Orten, D. J., Ohliger, S. J., Riazuddin, S., Morell, R. J., Khan, S., Riazuddin, S., Kremer, H., van Hauwe, P., Moller, C. G., Cremers, C. W. R. J., Ayuso, C., Heckenlively, J. R., Rohrschneider, K., Spandau, U., … Kimberling, W. J. (2002). CDH23 mutation and phenotype heterogeneity: A profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. American Journal of Human Genetics, 71(2), 262–275. https://doi.org/10.1086/341558
Bolz, H., von Brederlow, B., Ramírez, A., Bryda, E. C., Kutsche, K., Nothwang, H. G., Seeliger, M., del C-Salcedó Cabrera, M., Vila, M. C., Molina, O. P., Gal, A., & Kubisch, C. (2001). Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nature Genetics, 27(1), 108–112. https://doi.org/10.1038/83667
Hawi, Z., Tong, J., Dark, C., Yates, H., Johnson, B., & Bellgrove, M. A. (2018). The role of cadherin genes in five major psychiatric disorders: A literature update. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177(2), 168–180. https://doi.org/10.1002/ajmg.b.32592
Hoefsloot, L. H., Feenstra, I., Kunst, H. P. M., & Kremer, H. (2014). Genotype phenotype correlations for hearing impairment: Approaches to management. Clinical Genetics, 85(6), 514–523. https://doi.org/10.1111/cge.12339
Miyagawa, M., Nishio, S., & Usami, S. (2012). Prevalence and clinical features of hearing loss patients with CDH23 mutations: A large cohort study. PLoS ONE, 7(8), e40366. https://doi.org/10.1371/journal.pone.0040366
Redies, C., Hertel, N., & Hübner, C. A. (2012). Cadherins and neuropsychiatric disorders. Brain Research, 1470, 130–144. https://doi.org/10.1016/j.brainres.2012.06.020
Sotomayor, M., Weihofen, W. A., Gaudet, R., & Corey, D. P. (2010). Structural determinants of cadherin-23 function in hearing and deafness. Neuron, 66(1), 85–100. https://doi.org/10.1016/j.neuron.2010.03.028
Stark, T. A., McKinney, A. M., Palmer, C. S., Maisel, R. H., & Truwit, C. L. (2009). Dilation of the subarachnoid spaces surrounding the cranial nerves with petrous apex cephaloceles in usher syndrome. American Journal of Neuroradiology, 30(2), 434–436. https://doi.org/10.3174/ajnr.A1283
Takahashi, S., Mui, V. J., Rosenberg, S. K., Homma, K., Cheatham, M. A., & Zheng, J. (2016). Cadherin 23-C regulates microtubule networks by modifying CAMSAP3’s function. Scientific Reports, 6(1), 28706. https://doi.org/10.1038/srep28706
Tsukada, K., Nishio, S., Takumi, Y., & Usami, S. (2024). Comparison of vestibular function in hereditary hearing loss patients with GJB2, CDH23, and SLC26A4 variants. Scientific Reports, 14(1), 10596. https://doi.org/10.1038/s41598-024-61442-3
Usami, S.-I., Isaka, Y., Miyagawa, M., & Nishio, S.-Y. (2022). Variants in CDH23 cause a broad spectrum of hearing loss: From non-syndromic to syndromic hearing loss as well as from congenital to age-related hearing loss. Human Genetics, 141(3–4), 903–914. https://doi.org/10.1007/s00439-022-02431-2
Vanniya. S, P., Srisailapathy, C. R. S., & Kunka Mohanram, R. (2018). The tip link protein cadherin-23: From hearing loss to cancer. Pharmacological Research, 130, 25–35. https://doi.org/10.1016/j.phrs.2018.01.026
Zhao, T., Ma, P., Zhao, F., Zheng, T., Yan, B., Zhang, Q., Yuan, J., Hu, B., Yang, Y., Hu, J., Geng, R., Hu, B. H., Sun, T., Zheng, Q. Y., & Li, B. (2021). Phenotypic differences in the inner ears of CBA/CaJ and C57BL/6J mice carrying missense and single base pair deletion mutations in the CHD23 gene. Journal of Neuroscience Research, 99(10), 2743–2758. https://doi.org/10.1002/jnr.24905
Headache, Migraine, and Facial Pain
7.2.2 Cerebrospinal fluid (CSF) fistula headache. (n.d.). ICHD-3. Retrieved September 2, 2026, from https://ichd-3.org/7-headache-attributed-to-non-vascular-intracranial-disorder/7-2-headache-attributed-to-low-cerebrospinal-fluid-pressure/7-2-2-csf-fistula-headache/
A1.6.6 Vestibular migraine. (n.d.). ICHD-3. Retrieved September 2, 2026, from https://ichd-3.org/appendix/a1-migraine/a1-6-episodic-syndromes-that-may-be-associated-with-migraine/a1-6-6-vestibular-migraine/
Abu-Arafeh, I., Hershey, A. D., Diener, H.-C., Tassorelli, C., & on behalf of the Clinical Trials Standing Committee and the Child and Adolescent Standing Committee of the International Headache Society. (2019). Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition. Cephalalgia, 39(7), 803–816. https://doi.org/10.1177/0333102419842188
Aleksovska, K., Hershey, A. D., Deen, M., De Icco, R., Lee, M. J., & Diener, H.-C. (2023). Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society. Cephalalgia, 43(10), 03331024231206162. https://doi.org/10.1177/03331024231206162
Ashina, H., Diener, H.-C., Tassorelli, C., Scher, A. I., Lipton, R. B., Pozo-Rosich, P., Sinclair, A. J., Chong, C. D., Finkel, A. G., Ashina, M., Schwedt, T. J., Dodick, D. W., & Terwindt, G. M. (2024). Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury. Cephalalgia, 44(3), 03331024241234068. https://doi.org/10.1177/03331024241234068
Bendtsen, L., Bigal, M., Cerbo, R., Diener, H., Holroyd, K., Lampl, C., Mitsikostas, D., Steiner, T., & Tfelt-Hansen, P. (2010). Guidelines for controlled trials of drugs in tension-type headache: Second edition. Cephalalgia, 30(1), 1–16. https://doi.org/10.1111/j.1468-2982.2009.01948.x
Callen, A. L., & Jenkins, K. (2026). Imaging and physiology across the high–low cerebrospinal fluid pressure spectrum: Navigating diagnostic uncertainty in headache practice. Headache: The Journal of Head and Face Pain, 66(6), 1405–1418. https://doi.org/10.1111/head.70096
Cook, C., Freeman, M. C., Ailani, J., Ehrlich, A., Grosberg, B., Kabbouche, M., Moriarty, M., Secora, K., VanderPluym, J., Klein, B., Birlea, M., & the American Headache Society Board of Directors. (2026). Towards a standardized process of onboarding advanced practice providers into headache medicine practices in the United States: Expert consensus from the American Headache Society practice management committee. Headache: The Journal of Head and Face Pain, 66(2), 502–510. https://doi.org/10.1111/head.70038
Diener, H. C., Ashina, M., Durand-Zaleski, I., Kurth, T., Lantéri-Minet, M., Lipton, R. B., Ollendorf, D. A., Pozo-Rosich, P., Tassorelli, C., & Terwindt, G. (2021). Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society. Cephalalgia, 41(3), 279–293. https://doi.org/10.1177/0333102421989247
Diener, H.-C., Tassorelli, C., Dodick, D. W., Silberstein, S. D., Lipton, R. B., Ashina, M., Becker, W. J., Ferrari, M. D., Goadsby, P. J., Pozo-Rosich, P., Wang, S.-J., Houle, T. T., Hoek, T. C. V. D., Martinelli, D., Terwindt, G. M., & on behalf of the International Headache Society Clinical Trials Committee. (2020). Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia, 40(10), 1026–1044. https://doi.org/10.1177/0333102420941839
Diener, H.-C., Tassorelli, C., Dodick, D. W., Silberstein, S. D., Lipton, R. B., Ashina, M., Becker, W. J., Ferrari, M. D., Goadsby, P. J., Pozo-Rosich, P., Wang, S.-J., Mandrekar, J., & on behalf of the International Headache Society Clinical Trials Standing Committee. (2019). Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition. Cephalalgia, 39(6), 687–710. https://doi.org/10.1177/0333102419828967
Ducros, A., & Biousse, V. (2015). Headache arising from idiopathic changes in CSF pressure. The Lancet Neurology, 14(6), 655–668. https://doi.org/10.1016/S1474-4422(15)00015-0
Goadsby, P. J., Evers, S., Gelfand, A. A., Lipton, R. B., May, A., Pozo-Rosich, P., Schoenen, J., Schwedt, T. J., Tassorelli, C., Terwindt, G., & Wang, S.-J. (2024). International Classification of Headache Disorders-4 – Work in progress. Cephalalgia, 44(2), 03331024241233937. https://doi.org/10.1177/03331024241233937
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. (2018). Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202
International Classification of Orofacial Pain, 1st edition (ICOP). (2020). Cephalalgia, 40(2), 129–221. https://doi.org/10.1177/0333102419893823
International Headache Society Clinical Trials Subcommittee members:, Tfelt-Hansen, P., Pascual, J., Ramadan, N., Dahlöf, C., D’Amico, D., Diener, H.-C., Hansen, J. M., Lanteri-Minet, M., Loder, E., McCrory, D., Plancade, S., & Schwedt, T. (2012). Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators. Cephalalgia, 32(1), 6–38. https://doi.org/10.1177/0333102411417901
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V., Jones, B., Lipton, R., Massiou, H., Meinert, C., Sandrini, G., Steiner, T., & Winter, P. (2000). Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia, 20(9), 765–786. https://doi.org/10.1046/j.1468-2982.2000.00117.x
May, A. (2020). Facial Pain is coming home. Cephalalgia, 40(3), 227–228. https://doi.org/10.1177/0333102420908506
Mollan, S. P., Fraser, C. L., Digre, K. B., Diener, H.-C., Lipton, R. B., Juhler, M., Miller, N. R., Pozo-Rosich, P., Togha, M., Brock, K., Dinkin, M. J., Chan, C. K. M., Tassorelli, C., Sinclair, A. J., Terwindt, G. M., & Jensen, R. H. (2023). Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension. Cephalalgia, 43(8), 03331024231197118. https://doi.org/10.1177/03331024231197118
Oskoui, M., Pringsheim, T., Holler-Managan, Y., Potrebic, S., Billinghurst, L., Gloss, D., Hershey, A. D., Licking, N., Sowell, M., Victorio, M. C., Gersz, E. M., Leininger, E., Zanitsch, H., Yonker, M., & Mack, K. (2019). Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology, 93(11), 487–499. https://doi.org/10.1212/WNL.0000000000008095
Potrebic, S., Tanveer, S., Becker, W. J., Burch, R., Cooke, L. J., Fenton, T., Fletcher, J. J., Gordon Perue, G. L., Hershey, A. D., Jackson, J. L., Kessel, S., Loder, E. W., Minen, M. T., Oskoui, M., Ramanan, V. K., Murren, M., Schwedt, T. J., Silberstein, S. D., Smith, D. B., … Pringsheim, T. (2026). Pharmacologic reatment for migraine prevention in adults practice guideline recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Neurology, 107(7), e214881. https://doi.org/10.1212/WNL.0000000000214881
Pozo-Rosich, P., Van Veelen, N., Caronna, E., Vaghi, G., Torres-Ferrus, M., Van Der Arend, B. W. H., Goadsby, P. J., Ashina, M., Wang, S.-J., Diener, H.-C., Tassorelli, C., & Terwindt, G. M. (2025). Guidelines of the International Headache Society for real-world evidence studies in migraine and cluster headache. Cephalalgia, 45(3), 03331024251318016. https://doi.org/10.1177/03331024251318016
Puledda, F., Sacco, S., Diener, H.-C., Ashina, M., Al-Khazali, H. M., Ashina, S., Burstein, R., Liebler, E., Cipriani, A., Chu, M. K., Cocores, A., Dodd-Glover, F., Ekizoğlu, E., Garcia-Azorin, D., Göbel, C. H., Goicochea, M. T., Hassan, A., Hirata, K., Hoffmann, J., … Tassorelli, C. (2024). International Headache Society global practice recommendations for preventive pharmacological treatment of migraine. Cephalalgia, 44(9), 03331024241269735. https://doi.org/10.1177/03331024241269735
Sacco, S., Ashina, M., Diener, H.-C., Haghdoost, F., Lee, M. J., Monteith, T. S., Jenkins, B., Peres, M. F. P., Pozo-Rosich, P., Ornello, R., Puledda, F., Sakai, F., Schwedt, T. J., Terwindt, G., Vaghi, G., Wang, S.-J., Ahmed, F., & Tassorelli, C. (2025). Setting higher standards for migraine prevention: A position statement of the International Headache Society. Cephalalgia, 45(2), 03331024251320608. https://doi.org/10.1177/03331024251320608
Schwedt, T. J., Tassorelli, C., Silberstein, S. D., Szperka, C. L., Kurth, T., Pozo-Rosich, P., Amin, F. M., Lipton, R. B., Dodick, D. W., Ashina, M., Diener, H.-C., & Terwindt, G. M. (2022). Guidelines of the international headache society for clinic-based headache registries, 1st edition. Cephalalgia, 42(11–12), 1099–1115. https://doi.org/10.1177/03331024221099035
Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012). Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology, 78(17), 1337–1345. https://doi.org/10.1212/WNL.0b013e3182535d20
Silberstein, S., Tfelt-Hansen, P., Dodick, D., Limmroth, V., Lipton, R., Pascual, J., Wang, S., & for the Task Force of the International Headache Society Clinical Trials Subcommittee. (2008). Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia, 28(5), 484–495. https://doi.org/10.1111/j.1468-2982.2008.01555.x
Simpson, D. M., Hallett, M., Ashman, E. J., Comella, C. L., Green, M. W., Gronseth, G. S., Armstrong, M. J., Gloss, D., Potrebic, S., Jankovic, J., Karp, B. P., Naumann, M., So, Y. T., & Yablon, S. A. (2016). Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 86(19), 1818–1826. https://doi.org/10.1212/WNL.0000000000002560
Steiner, T. J. (2008). Ethical issues arising from commercial sponsorship and from relationships with the pharmaceutical industry—Report and recommendations of the Ethics Subcommittee of the International Headache Society. Cephalalgia, 28(3_suppl), 1–25. https://doi.org/10.1111/j.1468-2982.2007.01402.x
Tassorelli, C., Diener, H.-C., Dodick, D. W., Silberstein, S. D., Lipton, R. B., Ashina, M., Becker, W. J., Ferrari, M. D., Goadsby, P. J., Pozo-Rosich, P., Wang, S.-J., & for the International Headache Society Clinical Trials Standing Committee. (2018). Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults. Cephalalgia, 38(5), 815–832. https://doi.org/10.1177/0333102418758283
Tassorelli, C., Diener, H.-C., Silberstein, S. D., Dodick, D. W., Goadsby, P. J., Jensen, R. H., Magis, D., Pozo-Rosich, P., Yuan, H., Martinelli, D., Hoek, T. V. D., Deen, M., Ashina, M., & Terwindt, G. M. (2021). Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia, 41(11–12), 1135–1151. https://doi.org/10.1177/03331024211010413
Tfelt-Hansen, P., Bjarnason, N., Dahlöf, C., Derry, S., Loder, E., Massiou, H., & for the Task Force on Adverse Events in Migraine Trials of the Subcommittee on Clinical Trial of the International Headache Society. (2008). Evaluation and registration of adverse events in clinical drug trials in migraine. Cephalalgia, 28(7), 683–688. https://doi.org/10.1111/j.1468-2982.2008.01600.x
The International Classification of Headache Disorders. (n.d.). ICHD-3. Retrieved September 2, 2026, from https://ichd-3.org/
Valentine, M. J., Kramer, H. D., Kim, J., Pettinelli, N., & Hu, T. (2023). Heart break or headache: A case report of sumatriptan-induced takotsubo syndrome. Cureus. https://doi.org/10.7759/cureus.45990
Intracranial Hypertension ( IH)
Baixauli, E. P. (n.d.). Investigation into the choroid plexus molecular mechanisms underlying idiopathic intracranial hypertension.
Chen, B. S., Newman, N. J., & Biousse, V. (2021). Atypical presentations of idiopathic intracranial hypertension. Taiwan Journal of Ophthalmology, 11(1), 25–38. https://doi.org/10.4103/tjo.tjo_69_20
Eide, P. K., Pripp, A. H., Ringstad, G., & Valnes, L. M. (2021). Impaired glymphatic function in idiopathic intracranial hypertension. Brain Communications, 3(2), fcab043. https://doi.org/10.1093/braincomms/fcab043
Grech, O., Clouter, A., Mitchell, J. L., Alimajstorovic, Z., Ottridge, R. S., Yiangou, A., Roque, M., Tahrani, A. A., Nicholls, M., Taylor, A. E., Shaheen, F., Arlt, W., Lavery, G. G., Shapiro, K., Mollan, S. P., & Sinclair, A. J. (2021). Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure. Brain Communications, 3(3), fcab202. https://doi.org/10.1093/braincomms/fcab202
Hashemizad, A., Dela Cruz, J., Narayan, A., & Maxwell, A. J. (2025). Hyperventilation during rest and exercise in orthostatic intolerance and Spiky-Leaky Syndrome. Frontiers in Neurology, 16, 1512671. https://doi.org/10.3389/fneur.2025.1512671
Hepworth, E. J., Love, A. V., & Hartford, R. L. (2021). Intracranial hypertension secondary to venous outflow obstruction. Journal of Neurological Surgery Part B: Skull Base, 82(S 02), OD068. https://doi.org/10.1055/s-0041-1725347
Higgins, J., Garnett, M., Pickard, J., & Axon, P. (2016). An evaluation of styloidectomy as an adjunct or alternative to jugular stenting in idiopathic intracranial hypertension and disturbances of cranial venous outflow. Journal of Neurological Surgery Part B: Skull Base, 78(02), 158–163. https://doi.org/10.1055/s-0036-1594238
Higgins, J. N. P., Pickard, J. D., & Lever, A. M. L. (2017). Chronic fatigue syndrome and idiopathic intracranial hypertension: Different manifestations of the same disorder of intracranial pressure? Medical Hypotheses, 105, 6–9. https://doi.org/10.1016/j.mehy.2017.06.014
Higgins, N., Trivedi, R., Greenwood, R., & Pickard, J. (2015). Brain slump caused by jugular venous stenoses treated by stenting: A hypothesis to link spontaneous intracranial hypotension with idiopathic intracranial hypertension. Journal of Neurological Surgery Reports, 76(01), e188–e193. https://doi.org/10.1055/s-0035-1555015
Hornby, C., Mollan, S. P., Botfield, H., O’Reilly, M. W., & Sinclair, A. J. (2018). Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. Journal of Neuro-Ophthalmology, 38(4), 522–530. https://doi.org/10.1097/WNO.0000000000000684
Hulens, M., Rasschaert, R., Vansant, G., Stalmans, I., Bruyninckx, F., & Dankaerts, W. (2018). The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: Exploration of a shared pathophysiology. Journal of Pain Research, Volume 11, 3129–3140. https://doi.org/10.2147/JPR.S186878
Krajnc, N., Itariu, B., Macher, S., Marik, W., Harreiter, J., Michl, M., Novak, K., Wöber, C., Pemp, B., & Bsteh, G. (2023). Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension. The Journal of Headache and Pain, 24(1), 89. https://doi.org/10.1186/s10194-023-01631-z
Kranz, P. G., Amrhein, T. J., Brinjikji, W., Callen, A. L., Carroll, I., Chazen, J. L., Cutsforth-Gregory, J., Friedman, D. I., Hutchins, T. A., Lehman, V. T., Madhavan, A. A., Mamlouk, M. D., Mark, I. T., Maya, M. M., Moser, F. G., Parikh, S. K., Schievink, W. I., Shah, L. M., Shah, V. N., … Jordan, J. E. (2025). Consensus guidelines on diagnostic brain and spine imaging of spontaneous intracranial hypotension. American Journal of Neuroradiology, 46(12), 2457–2467. https://doi.org/10.3174/ajnr.A9017
Maxwell, A. J., & Wardly, D. (2024). The complex path to intracranial hypertension and CSF leak in those with hypermobility and dysautonomia; the theory of spiky-leaky syndrome. MAR Pediatrics, 05(03), 86.
Mitchell, J. L., Mollan, S. P., Vijay, V., & Sinclair, A. J. (2019). Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension. Current Opinion in Neurology, 32(3), 422–431. https://doi.org/10.1097/WCO.0000000000000690
Moes, K. (2026). “Just lose weight”: Weight-based medical bias and experiential expertise in intracranial hypertension. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1785195
Moes, K., & Kent, M. (2025). Rarely done, poorly utilised and tokenistic: Investigating the meaningful engagement of people with lived experience of intracranial hypertension in research about intracranial hypertension. Including Disability, 6. https://doi.org/10.51357/id.v6i.311
Mollan, S. P., Tahrani, A. A., & Sinclair, A. J. (2021). The potentially modifiable risk factor in idiopathic intracranial hypertension: Body weight. Neurology Clinical Practice, 11(4). https://doi.org/10.1212/CPJ.0000000000001063
Rees, J., Moes, K., Devine, A., Clark, M., Sambell, R., Laws, S., & Cruickshank, T. (2025). Co-design of a weekly meal box for neurological conditions: Findings from consumer and healthcare provider collaborative workshops. Health Expectations, 28(5), e70412. https://doi.org/10.1111/hex.70412
Sattur, M. G., Amans, M., Fargen, K. M., Huisman, T. A. G. M., Brinjikji, W., Hui, F., Shingala, A., Vosler, P. S., Pereira, V. M., Hepworth, E., Dehdashti, A. R., Patsalides, A., Lo, S. L., & Spiotta, A. M. (2023). Angiographic evaluation of cranial venous outflow patterns in patients with and without idiopathic intracranial hypertension. Operative Neurosurgery, 24(1), e29–e35. https://doi.org/10.1227/ons.0000000000000413
Sinclair, A. J., Markey, K. A., Uldall, M., Cato, L., Miah, M., Botfield, H., Gonzalez, A. M., Jensen, R., & Hassan-Smith, G. (2016). Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases. Journal of Pain Research, 223. https://doi.org/10.2147/JPR.S80824
Yang, J.-W., Song, Q.-Y., Zhang, M.-X., Ai, J.-L., Wang, F., Kan, G.-H., Wu, B., & Zhu, S.-Q. (2022). Spaceflight-associated neuro-ocular syndrome: A review of potential pathogenesis and intervention. International Journal of Ophthalmology, 15(2), 336–341. https://doi.org/10.18240/ijo.2022.02.21
Zhou, D., Meng, R., Zhang, X., Guo, L., Li, S., Wu, W., Duan, J., Song, H., Ding, Y., & Ji, X. (2018). Intracranial hypertension induced by internal jugular vein stenosis can be resolved by stenting. European Journal of Neurology, 25(2), 365. https://doi.org/10.1111/ene.13512
Melanocortin-4 Receptor Deficiency
Argente, J., Clément, K., Duis, J., Farooqi, I. S., Kühnen, P., Miller, J. L., Roth, C. L., & van den Akker, E. (2025). Hyperphagia in rare melanocortin-4 receptor pathway diseases: Therapeutic options and assessing treatment response. Reviews in Endocrine and Metabolic Disorders, 26(6), 917–935. https://doi.org/10.1007/s11154-025-09984-3
Besnier, E., Clavier, T., Tonon, M. C., Pelletier, G., Dureuil, B., Castel, H., & Compère, V. (2018). Anesthetic drugs modulate feeding behavior and hypothalamic expression of the POMC polypeptide precursor and the NPY neuropeptide. BMC Anesthesiology, 18(1), 96. https://doi.org/10.1186/s12871-018-0557-x
Bhatnagar, P., Ahmad, N. N., Li, X., Coghlan, M., Kaplan, L. M., & Farooqi, I. S. (2025). Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency. Nature Medicine, 31(10), 3294–3296. https://doi.org/10.1038/s41591-025-03913-2
Böhm, M., Wolff, I., Scholzen, T. E., Robinson, S. J., Healy, E., Luger, T. A., Schwarz, T., & Schwarz, A. (2005). α-Melanocyte-Stimulating Hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. Journal of Biological Chemistry, 280(7), 5795–5802. https://doi.org/10.1074/jbc.M406334200
Brouwers, B., De Oliveira, E. M., Marti-Solano, M., Monteiro, F. B. F., Laurin, S.-A., Keogh, J. M., Henning, E., Bounds, R., Daly, C. A., Houston, S., Ayinampudi, V., Wasiluk, N., Clarke, D., Plouffe, B., Bouvier, M., Babu, M. M., Farooqi, I. S., & Mokrosiński, J. (2021). Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation. Cell Reports, 34(12), 108862. https://doi.org/10.1016/j.celrep.2021.108862
Bruschetta, G., Jin, S., Liu, Z.-W., Kim, J. D., & Diano, S. (2020). MC4R signaling in dorsal raphe nucleus controls feeding, anxiety, and depression. Cell Reports, 33(2), 108267. https://doi.org/10.1016/j.celrep.2020.108267
Cai, S., Yang, Q., Hou, M., Han, Q., Zhang, H., Wang, J., Qi, C., Bo, Q., Ru, Y., Yang, W., Gu, Z., Wei, R., Cao, Y., Li, X., & Zhang, Y. (2018). Α-Melanocyte-Stimulating Hormone protects early diabetic retina from blood-retinal barrier breakdown and vascular leakage via MC4R. Cellular Physiology and Biochemistry, 45(2), 505–522. https://doi.org/10.1159/000487029
Clemson, C. M., Yost, J., & Taylor, A. W. (2017). The role of alpha-MSH as a modulator of ocular immunobiology exemplifies mechanistic differences between melanocortins and steroids. Ocular Immunology and Inflammation, 25(2), 179–189. https://doi.org/10.3109/09273948.2015.1092560
Coll, A. P. (2018). Monogenic obesity; using drugs to bypass the problem. Cell Metabolism, 28(1), 1–2. https://doi.org/10.1016/j.cmet.2018.06.015
Copperi, F., Kim, J. D., & Diano, S. (2021). Role of the melanocortin system in the central regulation of cardiovascular functions. Frontiers in Physiology, 12, 725709. https://doi.org/10.3389/fphys.2021.725709
D’Agostino, G., & Diano, S. (2010). alpha-Melanocyte stimulating hormone: Production and degradation. Journal of Molecular Medicine, 88(12), 1195–1201. https://doi.org/10.1007/s00109-010-0651-0
de Souza Cordeiro, L. M., Elsheikh, A., Devisetty, N., Morgan, D. A., Ebert, S. N., Rahmouni, K., & Chhabra, K. H. (2021). Hypothalamic MC4R regulates glucose homeostasis through adrenaline-mediated control of glucose reabsorption via renal GLUT2 in mice. Diabetologia, 64(1), 181–194. https://doi.org/10.1007/s00125-020-05289-z
Decherf, S., Seugnet, I., Kouidhi, S., Lopez-Juarez, A., Clerget-Froidevaux, M.-S., & Demeneix, B. A. (2010). Thyroid hormone exerts negative feedback on hypothalamic type 4 melanocortin receptor expression. Proceedings of the National Academy of Sciences, 107(9), 4471–4476. https://doi.org/10.1073/pnas.0905190107
Do Carmo, J. M., Da Silva, A. A., Wang, Z., Fang, T., Aberdein, N., Perez De Lara, C. E., & Hall, J. E. (2017). Role of the brain melanocortins in blood pressure regulation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863(10), 2508–2514. https://doi.org/10.1016/j.bbadis.2017.03.003
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O’Rahilly, S. (2003). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. New England Journal of Medicine, 348(12), 1085–1095. https://doi.org/10.1056/NEJMoa022050
Fatima, M. T., Ahmed, I., Fakhro, K. A., & Akil, A. S. A.-S. (2022). Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies. Diabetes, Obesity and Metabolism, 24(4), 583–598. https://doi.org/10.1111/dom.14618
Gad, H., Dauleh, H., Pasha, M., Omer, I., Al-Barazenji, T., Alshafai, M., Malik, R. A., & Hussain, K. (n.d.). Early corneal nerve loss in children with melanocortin 4 receptor (MC4R) gene mutation related obesity.
Gad, H., Mohammed, I., Dauleh, H., Pasha, M., Al-Barazenji, T., Hussain, K., & Malik, R. A. (2024). Case report: Nerve fiber regeneration in children with melanocortin 4 receptor gene mutation related obesity treated with semaglutide. Frontiers in Endocrinology, 15, 1385463. https://doi.org/10.3389/fendo.2024.1385463
Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., DelValle, J., & Yamada, T. (1993). Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. Journal of Biological Chemistry, 268(20), 15174–15179. https://doi.org/10.1016/S0021-9258(18)82452-8
Gautron, L., Lee, C. E., Lee, S., & Elmquist, J. K. (2012). Melanocortin‐4 receptor expression in different classes of spinal and vagal primary afferent neurons in the mouse. Journal of Comparative Neurology, 520(17), 3933–3948. https://doi.org/10.1002/cne.23137
Gava, F. N., Da Silva, A. A., Dai, X., Harmancey, R., Ashraf, S., Omoto, A. C. M., Salgado, M. C., Moak, S. P., Li, X., Hall, J. E., & Do Carmo, J. M. (2021). Restoration of cardiac function after myocardial infarction by long-term activation of the CNS leptin-melanocortin system. JACC: Basic to Translational Science, 6(1), 55–70. https://doi.org/10.1016/j.jacbts.2020.11.007
Gooljar, S. B. (n.d.). Pharmacological therapies for monogenic obesity caused by MC4R dysfunction.
Granell, S., Mohammad, S., Ramanagoudr-Bhojappa, R., & Baldini, G. (2010). Obesity-linked variants of melanocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell surface by a chemical chaperone. Molecular Endocrinology, 24(9), 1805–1821. https://doi.org/10.1210/me.2010-0071
Grieb, Z. A., Cross, E. A., & Albers, H. E. (2022). Alpha-melanocyte-stimulating hormone (αMSH) modulates the rewarding properties of social interactions in an oxytocin receptor-dependent manner in Syrian hamsters (Mesocricetus Auratus). Physiology & Behavior, 252, 113828. https://doi.org/10.1016/j.physbeh.2022.113828
Herrera, G., Silvero C, M. J., Becerra, M. C., Lasaga, M., & Scimonelli, T. (2023). Modulatory role of α-MSH in hippocampal-dependent memory impairment, synaptic plasticity changes, oxidative stress, and astrocyte reactivity induced by short-term high-fat diet intake. Neuropharmacology, 239, 109688. https://doi.org/10.1016/j.neuropharm.2023.109688
Heyder, N. A., Kleinau, G., Speck, D., Schmidt, A., Zschunke, S., Szczepek, M., Bauer, B., Koch, A., Gallandi, M., Kwiatkowski, D., Bürger, J., Mielke, T., Beck-Sickinger, A. G., Hildebrand, P. W., Spahn, C. M. T., Hilger, D., Schacherl, M., Biebermann, H., Hilal, T., … Scheerer, P. (2021). Structures of active melanocortin-4 receptor–Gs-protein complexes with NDP-α-MSH and setmelanotide. Cell Research, 31(11), 1176–1189. https://doi.org/10.1038/s41422-021-00569-8
Hoke, T., Torigoe, T., & Hui, F. (2025a). E-017 Melanocortin-4 receptor deficiency is associated with cerebral venous congestion and intracranial pressure disorders. Journal of NeuroInterventional Surgery, 17(Suppl 1), A102–A103. https://doi.org/10.1136/jnis-2025-SNIS.133
Hoke, T., Torigoe, T., & Hui, F. (2025b). Melanocortin-4 receptor deficiency is associated with cerebral venous congestion and intracranial pressure disorders [Conference Presentation]. Society of NeuroInterventional Surgery Cerebral Venous and CSF Disorders Summit, Honolulu, HI, United States.
Huang, X.-M., Yang, W.-C., Liu, Y., Tang, D.-R., Wu, T., & Sun, F.-Y. (2020). Mutations in MC4R facilitate the angiogenic activity in patients with orbital venous malformation. Experimental Biology and Medicine, 245(11), 956–963. https://doi.org/10.1177/1535370220919056
Iepsen, E. W., Zhang, J., Thomsen, H. S., Hansen, E. L., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Holm, J.-C., & Torekov, S. S. (2018). Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist. Cell Metabolism, 28(1), 23-32.e3. https://doi.org/10.1016/j.cmet.2018.05.008
Krashes, M. J., Lowell, B. B., & Garfield, A. S. (2016). Melanocortin-4 receptor–regulated energy homeostasis. Nature Neuroscience, 19(2), 206–219. https://doi.org/10.1038/nn.4202
Krause, W. C., Rodriguez, R., Gegenhuber, B., Matharu, N., Rodriguez, A. N., Padilla-Roger, A. M., Toma, K., Herber, C. B., Correa, S. M., Duan, X., Ahituv, N., Tollkuhn, J., & Ingraham, H. A. (2021). Oestrogen engages brain MC4R signalling to drive physical activity in female mice. Nature, 599(7883), 131–135. https://doi.org/10.1038/s41586-021-04010-3
Kühnen, P., & Clément, K. (2022). Long-term MC4R agonist treatment in POMC-deficient patients. New England Journal of Medicine, 387(9), 852–854. https://doi.org/10.1056/NEJMc2207442
Li, H., Xu, Y., Jiang, Y., Jiang, Z., Otiz-Guzman, J., Morrill, J. C., Cai, J., Mao, Z., Xu, Y., Arenkiel, B. R., Huang, C., & Tong, Q. (2023). The melanocortin action is biased toward protection from weight loss in mice. Nature Communications, 14(1), 2200. https://doi.org/10.1038/s41467-023-37912-z
Li, L., Liang, J., Zhang, C., Liu, T., & Zhang, C. (2023). Peripheral actions and direct central–local communications of melanocortin 4 receptor signaling. Journal of Sport and Health Science, 12(1), 45–51. https://doi.org/10.1016/j.jshs.2021.02.001
Lisak, R., & Benjamins, J. (2017). Melanocortins, melanocortin receptors and multiple sclerosis. Brain Sciences, 7(8), 104. https://doi.org/10.3390/brainsci7080104
Litt, M. J., Okoye, G. D., Lark, D., Cakir, I., Moore, C., Barber, M. C., Atkinson, J., Fessel, J., Moslehi, J., & Cone, R. D. (2017). Loss of the melanocortin-4 receptor in mice causes dilated cardiomyopathy. eLife, 6, e28118. https://doi.org/10.7554/eLife.28118
Loos, R. J. F., & Yeo, G. S. H. (2022). The genetics of obesity: From discovery to biology. Nature Reviews. Genetics, 23(2), 120–133. https://doi.org/10.1038/s41576-021-00414-z
Manna, S. K., & Aggarwal, B. B. (1998). α-Melanocyte-Stimulating Hormone Inhibits the Nuclear Transcription Factor NF-κB Activation Induced by Various Inflammatory Agents. The Journal of Immunology, 161(6), 2873–2880. https://doi.org/10.4049/jimmunol.161.6.2873
Mastinu, A., Premoli, M., Maccarinelli, G., Grilli, M., Memo, M., & Bonini, S. A. (2018). Melanocortin 4 receptor stimulation improves social deficits in mice through oxytocin pathway. Neuropharmacology, 133, 366–374. https://doi.org/10.1016/j.neuropharm.2018.02.007
Metzger, P. J., Zhang, A., Carlson, B. A., Sun, H., Cui, Z., Li, Y., Jahnke, M. T., Layton, D. R., Gupta, M. B., Liu, N., Kostenis, E., Gavrilova, O., Chen, M., & Weinstein, L. S. (n.d.). A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice. The Journal of Clinical Investigation, 134(4), e165418. https://doi.org/10.1172/JCI165418
Mori, K., Okuma, H., Nakamura, S., Uchinuma, H., Kaga, S., Nakajima, H., Ogawa, Y., & Tsuchiya, K. (2023). Melanocortin-4 receptor in macrophages attenuated angiotensin II-induced abdominal aortic aneurysm in mice. Scientific Reports, 13(1), 19768. https://doi.org/10.1038/s41598-023-46831-4
Moscowitz, A. E., Asif, H., Lindenmaier, L. B., Calzadilla, A., Zhang, C., & Mirsaeidi, M. (2019). The importance of melanocortin receptors and their agonists in pulmonary disease. Frontiers in Medicine, 6, 145. https://doi.org/10.3389/fmed.2019.00145
Namjou, B., Stanaway, I. B., Lingren, T., Mentch, F. D., Benoit, B., Dikilitas, O., Niu, X., Shang, N., Shoemaker, A. H., Carey, D. J., Mirshahi, T., Singh, R., Nestor, J. G., Hakonarson, H., Denny, J. C., Crosslin, D. R., Jarvik, G. P., Kullo, I. J., Williams, M. S., & Harley, J. B. (2021). Evaluation of the MC4R gene across eMERGE network identifies many unreported obesity-associated variants. International Journal of Obesity, 45(1), 155–169. https://doi.org/10.1038/s41366-020-00675-4
Naser, A. A., Miyazaki, T., Wang, J., Takabayashi, S., Pachoensuk, T., & Tokumoto, T. (2021). MC4R mutant mice develop ovarian teratomas. Scientific Reports, 11(1), 3483. https://doi.org/10.1038/s41598-021-83001-w
Newman, E. A., Chai, B., Zhang, W., & Mulholland, M. W. (2006). Melanocortin-4 receptor activation mobilizes intracellular calcium and stimulates mitogen-activated kinase in GT1-1 cells. Journal of Surgical Research, 130(2), 172. https://doi.org/10.1016/j.jss.2005.11.033
Oya, M., Miyasaka, Y., Nakamura, Y., Tanaka, M., Suganami, T., Mashimo, T., & Nakamura, K. (2024). Age-related ciliopathy: Obesogenic shortening of melanocortin-4 receptor-bearing neuronal primary cilia. Cell Metabolism, 36(5), 1044-1058.e10. https://doi.org/10.1016/j.cmet.2024.02.010
Paisdzior, S., Dimitriou, I. M., Schöpe, P. C., Annibale, P., Scheerer, P., Krude, H., Lohse, M. J., Biebermann, H., & Kühnen, P. (2020). Differential signaling profiles of MC4R mutations with three different ligands. International Journal of Molecular Sciences, 21(4), 1224. https://doi.org/10.3390/ijms21041224
Reininghaus, N., Paisdzior, S., Höpfner, F., Jyrch, S., Cetindag, C., Scheerer, P., Kühnen, P., & Biebermann, H. (2022). A setmelanotide-like effect at MC4R is achieved by MC4R dimer separation. Biomolecules, 12(8), 1119. https://doi.org/10.3390/biom12081119
René, P., Lanfray, D., Richard, D., & Bouvier, M. (2021). Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity. JCI Insight, 6(4), e132778. https://doi.org/10.1172/jci.insight.132778
René, P., Le Gouill, C., Pogozheva, I. D., Lee, G., Mosberg, H. I., Farooqi, I. S., Valenzano, K. J., & Bouvier, M. (2010). Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity. The Journal of Pharmacology and Experimental Therapeutics, 335(3), 520–532. https://doi.org/10.1124/jpet.110.172098
Rinne, P., Penttinen, A.-M., Nordlund, W., Ahotupa, M., & Savontaus, E. (2013). α-MSH analogue attenuates blood pressure elevation in DOCA-salt hypertensive mice. PLoS ONE, 8(8), e72857. https://doi.org/10.1371/journal.pone.0072857
Robinson, K. C., Kemény, L. V., Fell, G. L., Hermann, A. L., Allouche, J., Ding, W., Yekkirala, A., Hsiao, J. J., Su, M. Y., Theodosakis, N., Kozak, G., Takeuchi, Y., Shen, S., Berenyi, A., Mao, J., Woolf, C. J., & Fisher, D. E. (2021). Reduced MC4R signaling alters nociceptive thresholds associated with red hair. Science Advances, 7(14), eabd1310. https://doi.org/10.1126/sciadv.abd1310
Rodríguez Rondón, A. V., Welling, M. S., Van Den Akker, E. L. T., Van Rossum, E. F. C., Boon, E. M. J., Van Haelst, M. M., Delhanty, P. J. D., & Visser, J. A. (2024). MC4R variants modulate α-MSH and setmelanotide induced cellular signaling at multiple levels. The Journal of Clinical Endocrinology & Metabolism, 109(10), 2452–2466. https://doi.org/10.1210/clinem/dgae210
Roubert, P., Dubern, B., Plas, P., Lubrano-Berthelier, C., Alihi, R., Auger, F., Deoliveira, D. B., Dong, J. Z., Basdevant, A., Thurieau, C., & Clément, K. (2010). Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response. Journal of Endocrinology, 207(2), 177–183. https://doi.org/10.1677/JOE-09-0336
Serbis, A., Kantza, E., Garoufou, M., Christou, M., Siomou, E., & Tigas, S. (2026). Genetic determinants of obesity: Mechanisms, clinical implications, and targeted therapies. Endocrine, 91(1), 227. https://doi.org/10.1007/s12020-026-04696-3
Serre, C., Busuttil, V., & Botto, J. ‐M. (2018). Intrinsic and extrinsic regulation of human skin melanogenesis and pigmentation. International Journal of Cosmetic Science, 40(4), 328–347. https://doi.org/10.1111/ics.12466
Shikdar, N., & Alghamdi, F. (2021). Influence of selective melanocortin-4 receptor antagonist HS014 on hypersensitivity after nervous system injuries in a model of rat neuropathic pain: A narrative review of the literature. Cureus. https://doi.org/10.7759/cureus.17681
Singh, M., & Mukhopadhyay, K. (2014). Alpha-Melanocyte Stimulating Hormone: An Emerging Anti-Inflammatory Antimicrobial Peptide. BioMed Research International, 2014, 1–10. https://doi.org/10.1155/2014/874610
Sohn, J.-W., Harris, L. E., Berglund, E. D., Liu, T., Vong, L., Lowell, B. B., Balthasar, N., Williams, K. W., & Elmquist, J. K. (2013). Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell, 152(3), 612–619. https://doi.org/10.1016/j.cell.2012.12.022
Spencer, J. D., Chavan, B., Marles, L. K., Kauser, S., Rokos, H., & Schallreuter, K. U. (2005). A novel mechanism in control of human pigmentation by β-melanocyte-stimulating hormone and 7-tetrahydrobiopterin. Journal of Endocrinology, 187(2), 293–302. https://doi.org/10.1677/joe.1.06275
Stepp, D. W., Osakwe, C. C., De Chantemele, E. J. B., & Mintz, J. D. (2013). Vascular effects of deletion of melanocortin-4 receptors in rats. Physiological Reports, 1(6), e00146. https://doi.org/10.1002/phy2.146
Sun, B., Vatanen, T., Jayasinghe, T. N., McKenzie, E., Murphy, R., & O’Sullivan, J. M. (2020). Desacetyl-α-MSH and α-MSH have sex specific interactions with diet to influence mouse gut morphology, metabolites and microbiota. Scientific Reports, 10(1), 18957. https://doi.org/10.1038/s41598-020-75786-z
Suominen, A., Saldo Rubio, G., Ruohonen, S., Szabó, Z., Pohjolainen, L., Ghimire, B., Ruohonen, S. T., Saukkonen, K., Ijas, J., Skarp, S., Kaikkonen, L., Cai, M., Wardlaw, S. L., Ruskoaho, H., Talman, V., Savontaus, E., Kerkelä, R., & Rinne, P. (2024). α-Melanocyte-stimulating hormone alleviates pathological cardiac remodeling via melanocortin 5 receptor. EMBO Reports, 25(4), 21. https://doi.org/10.1038/s44319-024-00109-6
Tan, H. Y., Steyn, F. J., Huang, L., Cowley, M., Veldhuis, J. D., & Chen, C. (2016). Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone. The Journal of Physiology, 594(24), 7309–7326. https://doi.org/10.1113/JP272770
Tooke, B. P., Yu, H., Adams, J. M., Jones, G. L., Sutton-Kennedy, T., Mundada, L., Qi, N. R., Low, M. J., & Chhabra, K. H. (2018). Hypothalamic POMC or MC4R deficiency impairs counterregulatory responses to hypoglycemia in mice. Molecular Metabolism, 20, 194–204. https://doi.org/10.1016/j.molmet.2018.11.004
Valli-Jaakola, K. (2007). Molecular genetic studies of melanocortin receptors in morbid obesity. University of Helsinki.
Vollbach, H., Brandt, S., Lahr, G., Denzer, C., von Schnurbein, J., Debatin, K.-M., & Wabitsch, M. (2017). Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort. International Journal of Obesity, 41(1), 13–22. https://doi.org/10.1038/ijo.2016.161
Wade, K. H., Lam, B. Y. H., Melvin, A., Pan, W., Corbin, L. J., Hughes, D. A., Rainbow, K., Chen, J.-H., Duckett, K., Liu, X., Mokrosiński, J., Mörseburg, A., Neaves, S., Williamson, A., Zhang, C., Farooqi, I. S., Yeo, G. S. H., Timpson, N. J., & O’Rahilly, S. (2021). Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort. Nature Medicine, 27(6), 1088–1096. https://doi.org/10.1038/s41591-021-01349-y
Wang, K., Mao, W., Zhang, X., Zhao, Y., Fan, K., Pan, D., Liu, H., Li, P., Hai, R., & Du, C. (2020). Neuroanatomy of melanocortin-4 receptor pathway in the mouse brain. Open Life Sciences, 15(1), 580–587. https://doi.org/10.1515/biol-2020-0063
Wang, S., Kahale, F., Naderi, A., Surico, P., Yin, J., Dohlman, T., Chen, Y., & Dana, R. (2024). Therapeutic effects of stimulating the melanocortin pathway in regulating ocular inflammation and cell death. Biomolecules, 14(2), 169. https://doi.org/10.3390/biom14020169
Wang, W., Guo, D.-Y., Lin, Y.-J., & Tao, Y.-X. (2019). Melanocortin regulation of inflammation. Frontiers in Endocrinology, 10, 683. https://doi.org/10.3389/fendo.2019.00683
Wang, X.-H., Wang, H.-M., Zhao, B.-L., Yu, P., & Fan, Z.-C. (2014). Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17. Journal of Molecular Endocrinology, 53(1), 17–29. https://doi.org/10.1530/JME-14-0005
Wang, Y., Bernard, A., Comblain, F., Yue, X., Paillart, C., Zhang, S., Reiter, J. F., & Vaisse, C. (2021). Melanocortin 4 receptor signals at the neuronal primary cilium to control food intake and body weight. Journal of Clinical Investigation, 131(9), e142064. https://doi.org/10.1172/JCI142064
Wortley, K. E., Anderson, K. D., Yasenchak, J., Murphy, A., Valenzuela, D., Diano, S., Yancopoulos, G. D., Wiegand, S. J., & Sleeman, M. W. (2005). Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metabolism, 2(6), 421–427. https://doi.org/10.1016/j.cmet.2005.11.004
Wu, Q., Chen, J., Hua, T., & Cai, J. (2023). Alpha-melanocyte-stimulating hormone-Mediated appetite regulation in the central nervous system. Neuroendocrinology, 113(9), 885–904. https://doi.org/10.1159/000530804
Zhang, Y., Bo, Q., Wu, W., Xu, C., Yu, G., Ma, S., Yang, Q., Cao, Y., Han, Q., Ru, Y., Liu, X., Hua Wei, R., Wang, F. E., Zhang, X., & Li, X. (2015). α-Melanocyte-stimulating hormone prevents glutamate excitotoxicity in developing chicken retina via MC4R-mediated down-regulation of microRNA-194. Scientific Reports, 5(1), 15812. https://doi.org/10.1038/srep15812
My Publications and Presentations
Hoke, T. (n.d.). Our Neuro Network | Community-based Support Network of Honor, Homeostasis, and Hope. Our Neuro Network. Our Neuro Network. Retrieved September 6, 2026, from https://ourneuronetwork.org
Hoke, T. (2023). Improving outcomes through patient empowerment at transition of care: A fall prevention program for stroke survivors. Dissertations. https://www.sigmarepository.org/dissertations/1566
Hoke, T. M. (2014). Improving outcomes through patient empowerment at transition of care: A fall prevention program for stroke survivors [Doctor of Nursing Practice Inquiry, University of Arizona]. Sigma Repository. https://www.sigmarepository.org/dissertations/1566
Hoke, T. M. (Host). (2026, February 21). Mast cell activation syndrome, chemical sensitivity, and jugular venous congestion: A big picture perspective [Broadcast]. https://ourneuronetwork.alitu.com/episode/921cc326-0231-4ea7-8232-e8bdb0299df8
Hoke, T. M., & Taylor-Piliae, R. E. (2013). Abstract TMP88: Slipping, tripping, and rapid ambulation are key fall triggers for stroke survivors. Stroke, 44(suppl_1), ATMP88–ATMP88. https://doi.org/10.1161/str.44.suppl_1.ATMP88
Hoke, T., & Taylor-Piliae, R. (2013). Slipping, tripping, and rapid ambulation are key fall triggers for stroke survivors[Poster Presentation]. American Heart Association Scientific Sessions: Best of American Heart Association Specialty Conferences, Dallas, TX, United States.
Hoke, T., Torigoe, T., & Hui, F. (2025). E-017 Melanocortin-4 receptor deficiency is associated with cerebral venous congestion and intracranial pressure disorders. Journal of NeuroInterventional Surgery, 17(Suppl 1), A102–A103. https://doi.org/10.1136/jnis-2025-SNIS.133
Taylor-Piliae, R. E., Hoke, T. M., Hepworth, J. T., Latt, L. D., Najafi, B., & Coull, B. M. (2014). Effect of Tai Chi on physical function, fall rates and quality of life among older stroke survivors. Archives of Physical Medicine and Rehabilitation, 95(5), 816–824. https://doi.org/10.1016/j.apmr.2014.01.001
Taylor-Piliae, R. E., Hoke, T. M., Najafi, B., & Coull, B. M. (2013). Abstract WP362: Stroke survivors in a 12-week yang-style tai chi intervention have fewer falls. Stroke, 44(suppl_1), AWP362–AWP362. https://doi.org/10.1161/str.44.suppl_1.AWP362
Taylor-Piliae, R., Hoke, T., Najafi, B., & Coull, B. (2013). Stroke survivors In a 12-week Tai Chi intervention have fewer falls [Poster Presentation]. American Heart Association International Stroke Conference, Honolulu, HI, United States.
Spontaneous Intracranial Hypotension and Cerebrospinal Fluid (CSF) Leak
7.2.2 Cerebrospinal fluid (CSF) fistula headache. (n.d.). ICHD-3. Retrieved September 2, 2026, from https://ichd-3.org/7-headache-attributed-to-non-vascular-intracranial-disorder/7-2-headache-attributed-to-low-cerebrospinal-fluid-pressure/7-2-2-csf-fistula-headache/
Abuabara, A. (n.d.). Cerebrospinal fluid rhinorrhoea: Diagnosis and management. Med Oral Patol Oral Cir Bucal.
Ahmed Elshanawany, F. M. (2024). Spontaneous cerebrospinal fluid rhinorrhea as a primary presentation of idiopathic intracranial hypertension, management strategies, and clinical outcome. Surgical Neurology International. https://doi.org/10.25259/SNI_560_2024
Alhathlol, H., Alsharef, F. K., Almedemgh, K. I., Binmushayt, T. H., Alkhreigi, S., Alharbi, M., Almutairi, M. F., Alkhaibary, A., & Aloraidi, A. (2026). Cerebrospinal fluid leak following traumatic skull base fractures: Predictors and outcomes. Surgical Neurology International. https://doi.org/10.25259/sni_178_2026
Alkan, O., Yildirim, T., Kizilkilic, O., Albayram, S., & Altinkaya, N. (2009). Pseudoarachnoiditis in spontaneous intracranial hypotension. Medical Journal of Trakya University. https://doi.org/10.5174/tutfd.2009.02293.1
Amrhein, T. J., McFatrich, M., Ehle, K., Malinzak, M. D., Gray, L., Kranz, P. G., Weant, E. H., & Zigler, C. K. (2023). Patient experience of spontaneous intracranial hypotension (SIH): Qualitative interviews for concept elicitation. Journal of Patient-Reported Outcomes, 7(1), 82. https://doi.org/10.1186/s41687-023-00625-4
Beck, D. J. (n.d.). Surgery for PDPH: Blebs and needle holes.
Bedarida, V., Labeyrie, M.-A., Eliezer, M., Saint-Maurice, J.-P., Jourdaine, C., Gargalas, S., Herman, P., Houdart, E., & Verillaud, B. (2020). Association of spontaneous cerebrospinal fluid rhinorrhea with transverse venous sinus stenosis: A retrospective matched case-control study. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.22660
Bidot, S., Levy, J. M., Saindane, A. M., Narayana, K. M., Dattilo, M., DelGaudio, J. M., Mattox, D. E., Oyesiku, N. M., Peragallo, J. H., Solares, C. A., Vivas, E. X., Wise, S. K., Newman, N. J., & Biousse, V. (2021). Spontaneous skull base cerebrospinal fluid leaks and their relationship to idiopathic intracranial hypertension. American Journal of Rhinology & Allergy. https://doi.org/10.1177/1945892420932490
Bidot, S., Levy, J. M., Saindane, A. M., Oyesiku, N. M., Newman, N. J., & Biousse, V. (2019). Do most patients with a spontaneous cerebrospinal fluid leak have idiopathic intracranial hypertension? Journal of Neuro-Ophthalmology : The Official Journal of the North American Neuro-Ophthalmology Society. https://doi.org/10.1097/wno.0000000000000761
Caplan, I. F., Powell, S. D., Almohaisin, A., Gudis, D. A., & Golub, J. S. (2026). Diagnostic Tools and Imaging for Skull Base Cerebrospinal Fluid Leak. Otolaryngologic Clinics of North America. https://doi.org/10.1016/j.otc.2025.12.006
Carbone, C., Bardi, E., Corni, M. G., Balboni, E., Filippini, N., Fiondella, L., Salemme, S., Vinceti, G., Molinari, M. A., Tondelli, M., Chiari, A., & Zamboni, G. (2022). Why can spontaneous intracranial hypotension cause behavioral changes? A case report and multimodality neuroimaging comparison with frontotemporal dementia. Cortex, 155, 322–332. https://doi.org/10.1016/j.cortex.2022.07.013
Cheema, S., Joy, C., Pople, J., Snape-Burns, J., Trevarthen, T., & Matharu, M. (2022). Patient experience of diagnosis and management of spontaneous intracranial hypotension: A cross-sectional online survey. BMJ Open, 12(1), e057438. https://doi.org/10.1136/bmjopen-2021-057438
Dai, J. B., Signore, A. G. D., Govindaraj, S., Bederson, J. B., Iloreta, A. M. C., & Shrivastava, R. K. (2020). Investigation of skull-based cerebrospinal fluid leak repair: A single-institution comprehensive study of 116 cases over 10 years. World Neurosurgery. https://doi.org/10.1016/j.wneu.2019.09.133
Dallan, I., Vinciguerra, A., Barucco, M., Turri-Zanoni, M., Ferrari, M., Georgalas, C., Emanuelli, E., Pasquini, E., Sollini, G., Serioli, S., Girolami, L. di, Neri, L., Canevari, F. R., Kuan, E. C., Alquatani, A., Zele, T. van, Rigante, M., Cristofani-Mencacci, L., Alobid, I., … Castelnuovo, P. (2026). Spontaneous cerebrospinal fluid leaks and encephaloceles: Multi-institutional collaborative retrospective analysis of 468 cases with special focus on recurrent cases. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. https://doi.org/10.1007/s00405-026-10446-y
Dobrocky, T., Nicholson, P., Häni, L., Mordasini, P., Krings, T., Brinjikji, W., Cutsforth-Gregory, J. K., Schär, R., Schankin, C., Gralla, J., Pereira, V. M., Raabe, A., Farb, R., Beck, J., & Piechowiak, E. I. (2022). Spontaneous intracranial hypotension: Searching for the CSF leak. The Lancet Neurology, 21(4), 369–380. https://doi.org/10.1016/S1474-4422(21)00423-3
Eide, J. G., Mason, W., Ray, A., Carey, J., Cook, B., & Craig, J. R. (2024). Systematic review of errors on beta-2 transferrin gel electrophoresis testing of rhinorrhea and otorrhea. International Forum of Allergy & Rhinology, 14(6), 1016–1025. https://doi.org/10.1002/alr.23293
Erickson, T. S., Patel, E. J., & Loftus, P. A. (2026). Clinical presentation and epidemiology of traumatic and iatrogenic cerebrospinal fluid leaks. Otolaryngologic Clinics of North America. https://doi.org/10.1016/j.otc.2025.12.009
Filip, P., Patel, E. A., Khalife, S., Baird, A. M., Dominy, C., Joshi, K., Feng, R., Munich, S., Stosic, M., Szewka, A. J., Shrivastava, R., Govindaraj, S., Papagiannopoulos, P., Batra, P. S., & Tajudeen, B. A. (2024). Multiple skull base defects in the setting of spontaneous cerebrospinal fluid rhinorrhea; a dual institution view. American Journal of Otolaryngology. https://doi.org/10.1016/j.amjoto.2023.104048
Goldberg, J., Häni, L., Jesse, C. M., Zubak, I., Piechowiak, E. I., Gralla, J., Dobrocky, T., Beck, J., & Raabe, A. (2021). Spontaneous intracranial hypotension without CSF leakage—Concept of a pathological cranial to spinal fluid shift. Frontiers in Neurology, 12, 760081. https://doi.org/10.3389/fneur.2021.760081
Hepworth, E. J., Love, A. V., & Hartford, R. L. (2021). Intracranial hypertension secondary to venous outflow obstruction. Journal of Neurological Surgery Part B: Skull Base, 82(S 02), OD068. https://doi.org/10.1055/s-0041-1725347
Higgins, J. N., Axon, P. R., & Macfarlane, R. (2020). Spontaneous intracranial hypotension complicated by subdural effusions treated by surgical relief of cranial venous outflow obstruction. Journal of Neurological Surgery Reports, 81(04), e59–e65. https://doi.org/10.1055/s-0040-1722268
Higgins, N., Trivedi, R., Greenwood, R., & Pickard, J. (2015). Brain slump caused by jugular venous stenoses treated by stenting: A hypothesis to link spontaneous intracranial hypotension with idiopathic intracranial hypertension. Journal of Neurological Surgery Reports, 76(01), e188–e193. https://doi.org/10.1055/s-0035-1555015
Jesse, C. M., Häni, L., Fung, C., Ulrich, C. T., Schär, R. T., Dobrocky, T., Piechowiak, E. I., Goldberg, J., Schankin, C., Sintonen, H., Beck, J., & Raabe, A. (2022). The impact of spontaneous intracranial hypotension on social life and health-related quality of life. Journal of Neurology, 269(10), 5466–5473. https://doi.org/10.1007/s00415-022-11207-7
K, P., N, P., Silambu, M., C, R., & C, E. (2026). Etiology and evidence-based management of CSF rhinorrhea: Clinical outcomes in the endoscopic era. Asian Journal of Medical Sciences. https://doi.org/10.71152/ajms.v17i3.5107
Lashkarivand, A., & Eide, P. K. (2022). Brain sagging dementia—Diagnosis, treatment, and outcome. Neurology, 98(19), 798–805. https://doi.org/10.1212/WNL.0000000000200511
Liaw, V., McCreary, M., & Friedman, D. I. (2023). Quality of life in patients with confirmed and suspected spinal CSF leaks. Neurology, 101(23), e2411–e2422. https://doi.org/10.1212/WNL.0000000000207763
Lipschitz, N., Hazenfield, J. M., Breen, J. T., & Samy, R. N. (2019). Laboratory testing and imaging in the evaluation of cranial cerebrospinal fluid leaks and encephaloceles. Current Opinion in Otolaryngology & Head and Neck Surgery. https://doi.org/10.1097/moo.0000000000000578
Liu, Y. (2006). Cerebrospinal fluid leak after traumatic skull base fracture: The cause and treatment.
Massey, T. H., & Robertson, N. P. (2021). Spontaneous intracranial hypotension: Features, diagnosis and management. Journal of Neurology, 268(4), 1555–1557. https://doi.org/10.1007/s00415-021-10500-1
Mehta, D., Cheema, S., Davagnanam, I., & Matharu, M. (2023). Diagnosis and treatment evaluation in patients with spontaneous intracranial hypotension. Frontiers in Neurology, 14, 1145949. https://doi.org/10.3389/fneur.2023.1145949
O’’Leary, S., Gowda, P., Prabhakar, A., Jenkins, A., Darko, K., Azam, F., Robledo, A., Luna, A. E., Bonsrah, N. A., Still, M. E. H., Aoun, S. G., Whittemore, B. A., Barrie, U., Braga, B. P., & Totimeh, T. (2024). Evidence-based approaches to cranial cerebrospinal fluid leaks in low- and middle-income countries: A systematic review of the literature. Neurosurgical Review. https://doi.org/10.1007/s10143-024-03162-w
Omer, M., Wolf, K., Overstijns, M., El Rahal, A., Lützen, N., Urbach, H., Zander, C., Krismer, L., Klingler, J.-H., Hohenhaus, M., Shah, M., Beck, J., & Volz, F. (2026). Return to work – Estimated socioeconomic impact of spontaneous intracranial hypotension and effects of neurosurgical treatment. Frontiers in Neurology, 17, 1738826. https://doi.org/10.3389/fneur.2026.1738826
Onder, H. (2021). Association of spontaneous cerebrospinal fluid rhinorrhea with transverse venous sinus stenosis: A retrospective matched case-control study. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.22698
Palmer, R. C., D. Farquhar, Nina W. Zhao, A. Chiu, N. Adappa, J. (2016). Cerebrospinal fluid rhinorrhea secondary to idiopathic intracranial hypertension: Long-term outcomes of endoscopic repairs. American Journal of Rhinology & Allergy. https://doi.org/10.2500/ajra.2016.30.4319
Pasumarthi, A., Luo, A., Shah, H., & Carroll, I. (2020). Letter: Considering cerebrospinal fluid leaks in Ehlers-Danlos Patients: raising awareness amongst neurosurgeons. Neurosurgery Open, 1(4). https://doi.org/10.1093/neuopn/okaa016
Pérez, M. A., Bialer, O. Y., Bruce, B. B., Newman, N. J., & Biousse, V. (2013). Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. Journal of Neuro-Ophthalmology : The Official Journal of the North American Neuro-Ophthalmology Society. https://doi.org/10.1097/wno.0b013e318299c292
Radu, R. A., Department of Neurology, University Emergency Hospital Bucharest, Bucharest, Romania, Department of Neurology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Oana Terecoasa, E., Department of Neurology, University Emergency Hospital Bucharest, Bucharest, Romania, Department of Neurology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Elena Oana Terecoasa, MD, PhD, Department of Neurology, University Emergency Hospital Bucharest, 169 Independentei Street, District 5, 050098, Bucharest, Romania, Phone: +40744345734; E-mail: oana_ter@yahoo.com, Nicoleta Marinescu, A., Department of Radiology and Medical Imaging, University Emergency Hospital Bucharest, Bucharest, Romania, Department of Radiology and Medical Imaging, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Enache, I., Department of Neurology, University Emergency Hospital Bucharest, Bucharest, Romania, Tiu, C., Department of Neurology, University Emergency Hospital Bucharest, Bucharest, Romania, & Department of Neurology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. (2021). Cranial cerebrospinal fluid leak and intracranial hypotension syndrome – a case report. Journal of Medicine and Life, 14(4), 587–590. https://doi.org/10.25122/jml-2021-0090
Roshchina, D. V., Годков, И. М., Grin, А. А., Ai, K., & Гаров, Е. В. (2025). Features of diagnosing cerebrospinal fluid leak in patients with severe traumatic brain injury. Russian Journal of Neurosurgery. https://doi.org/10.63769/1683-3295-2025-27-2-161-170
Schievink, W. I. (n.d.). Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension.
Schievink, W. I., Maya, M., Tay, A. S.-M. S., Tache, R. B., Chu, R., Moser, F. G., Prasad, R. S., Nuno, M. A., & Lewis, R. A. (2026). Characteristics of patients with bibrachial amyotrophy due to spontaneous spinal CSF leaks. Neurology, 107(7), e218492. https://doi.org/10.1212/WNL.0000000000218492
Scoffings, D. J. (2021). Imaging of acquired skull base cerebrospinal fluid leaks. Neuroimaging Clinics of North America. https://doi.org/10.1016/j.nic.2021.05.009
Sk, B., & Ma, J. (n.d.). Spontaneous intracranial hypotension causing reversible frontotemporal dementia.
Steiert, C., Kraus, L. M., Roelz, R., Urbach, H., Beck, J., Meckel, S., & Grauvogel, J. (2022). Surgical repair of skull base CSF leaks after cisternography diagnosis: Analysis of validity and surgical outcome and impact on future treatment strategies. BioMed Research International. https://doi.org/10.1155/2022/8740352
Tlemcani, Z. C., Said, D., Jawad, L., Cherif, E. A., & Miloudi, G. (2026). Spontaneous cerebrospinal fluid leak in the clivus about two cases and review of literature. Radiology Case Reports, 21(7), 2942–2948. https://doi.org/10.1016/j.radcr.2026.03.064
Volz, F., Omer, M., Overstijns, M., Rahal, A. E., Hohenhaus, M., Klingler, J.-H., Lützen, N., Urbach, H., Zander, C., Carroll, I., Beck, J., & Wolf, K. (2026). Toward quantifying disability in spontaneous intracranial hypotension: A patient-derived disability weight. Cephalalgia, 46(4), 03331024261444662. https://doi.org/10.1177/03331024261444662
Volz, F., Wolf, K., Fung, C., Carroll, I., Lahmann, C., Lützen, N., Urbach, H., Klingler, J.-H., Beck, J., & El Rahal, A. (2024). Impact of spinal CSF leaks on quality of life and mental health and long-term reversal by surgical closure. Neurology: Clinical Practice, 14(2), e200272. https://doi.org/10.1212/CPJ.0000000000200272
Wei, T.-T., Huang, H., Chen, G., & He, F.-F. (2021). Management of an intracranial hypotension patient with diplopia as the primary symptom: A case report. World Journal of Clinical Cases, 9(22), 6544–6551. https://doi.org/10.12998/wjcc.v9.i22.6544
Welby, J. P., Mark, I. T., Carr, C. M., Benson, J. C., Verdoorn, J. T., & Johnson-Tesch, B. (2026). Rapid systemic absorption of epidural iodinated contrast: Observations from multilevel blood patching. American Journal of Neuroradiology, 47(8), 2209–2213. https://doi.org/10.3174/ajnr.A9226
Yang, Z., Wang, B., Wang, C., & Liu, P. (2011). Primary spontaneous cerebrospinal fluid rhinorrhea: A symptom of idiopathic intracranial hypertension? Journal of Neurosurgery. https://doi.org/10.3171/2011.3.jns101447
Zapalac, J. S., Marple, B. F., & Schwade, N. D. (2002). Skull base cerebrospinal fluid fistulas: A comprehensive diagnostic algorithm. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. https://doi.org/10.1067/mhn.2002.125755
Suicide
988 Lifeline. (n.d.). 988 Lifeline. Retrieved September 6, 2026, from https://988lifeline.org/
Allen, K. J. D., Bozzay, M. L., & Edenbaum, E. R. (2019). Neurocognition and suicide risk in adults. Current Behavioral Neuroscience Reports, 6(4), 151–165. https://doi.org/10.1007/s40473-019-00189-y
Bach, H., & Arango, V. (2012). Neuroanatomy of serotonergic abnormalities in suicide (Y. Dwivedi, Ed.). CRC Press/Taylor & Francis. http://www.ncbi.nlm.nih.gov/books/NBK107204/
Balcioglu, Y. H., & Kose, S. (2018). Neural substrates of suicide and suicidal behaviour: From a neuroimaging perspective. Psychiatry and Clinical Psychopharmacology, 28(3), 314–328. https://doi.org/10.1080/24750573.2017.1420378
Ballard, E. D., & Lamontagne, S. J. (2025). Neuroimaging and suicide-specific stimuli. Neuropsychopharmacology, 50(1), 308–309. https://doi.org/10.1038/s41386-024-01936-w
Bengoechea-Fortes, S. de la P., Ramírez-Expósito, M. J., & Martínez-Martos, J. M. (2024). Suicide, neuroinflammation and other physiological alterations. European Archives of Psychiatry and Clinical Neuroscience, 274(5), 1037–1049. https://doi.org/10.1007/s00406-023-01584-z
Braun, L. T., Vogel, F., & Reincke, M. (2022). Long‐term morbidity and mortality in patients with Cushing’s syndrome. Journal of Neuroendocrinology, 34(8), e13113. https://doi.org/10.1111/jne.13113
Brown, S.-L., Botsis, A. J., & Van Praag, H. M. (1992). Suicide: CSF and neuroendocrine challenge studies. International Review of Psychiatry, 4(2), 141–148. https://doi.org/10.3109/09540269209066311
Bryant, R. A., Breukelaar, I. A., Williamson, T., Felmingham, K., Williams, L. M., & Korgaonkar, M. S. (2024). The neural connectome of suicidality in adults with mood and anxiety disorders. Nature Mental Health, 2(11), 1342–1349. https://doi.org/10.1038/s44220-024-00325-y
Carballo, J. J., Akamnonu, C. P., & Oquendo, M. A. (2008). Neurobiology of suicidal behavior. An integration of biological and clinical findings. Archives of Suicide Research : Official Journal of the International Academy for Suicide Research, 12(2), 93–110. https://doi.org/10.1080/13811110701857004
Chen, M., Gao, M., Shao, R., Tong, H., Liu, J. M., Cheung, A. K., & Lee, T. M. C. (2026). Chronic stress modulates the relationship between acute stress-related cortical-limbic circuit functional connectivity and depression symptoms. Journal of Affective Disorders, 395(Pt B), 120725. https://doi.org/10.1016/j.jad.2025.120725
Dombrovski, A. Y., & Hallquist, M. N. (2017). The decision neuroscience perspective on suicidal behavior: Evidence and hypotheses. Current Opinion in Psychiatry, 30(1), 7–14. https://doi.org/10.1097/YCO.0000000000000297
Dwivedi, Y. (Ed.). (2012). The neurobiological basis of suicide. CRC Press/Taylor & Francis. http://www.ncbi.nlm.nih.gov/books/NBK107209/
Eisenlohr-Moul, T. A. (2026, September 8). Hormones, the brain, and female suicide risk. In Hormones, the brain, and female suicide risk. https://bbrfoundation.org/event/hormones-brain-and-female-suicide-risk
Erhardt, S., Lim, C. K., Linderholm, K. R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T. T., Träskman-Bendz, L., Guillemin, G. J., & Brundin, L. (2013). Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology, 38(5), 743–752. https://doi.org/10.1038/npp.2012.248
Ferrer-Cairols, I., Baquero, M., Salvador, A., Montoliu, T., Crespo-Sanmiguel, I., Pulopulos, M., Hidalgo, V., Gómez, E., López-Cuevas, R., Cuevas, A., & Martín, N. (2022). Depression and suicide risk in mild cognitive impairment: The role of alzheimer’s disease biomarkers. Psicothema, 4(34), 553–561. https://doi.org/10.7334/psicothema2022.103
Gadad, B. S., Vargas-Medrano, J., Ramos, E. I., Najera, K., Fagan, M., Forero, A., & Thompson, P. M. (2021). Altered levels of interleukins and neurotrophic growth factors in mood disorders and suicidality: An analysis from periphery to central nervous system. Translational Psychiatry, 11(1), 341. https://doi.org/10.1038/s41398-021-01452-1
Galfalvy, H., Currier, D., Oquendo, M. A., Sullivan, G., Huang, Y.-Y., & John Mann, J. (2009). Lower CSF MHPG predicts short-term risk for suicide attempt. The International Journal of Neuropsychopharmacology, 12(10), 1327. https://doi.org/10.1017/S1461145709990228
González-Castro, T. B., Almeida De La O, P. D. L. A., Tovilla-Zárate, C. A., López-Narváez, M. L., Genis Mendoza, A. D., Juárez-Rojop, I. E., Pérez-Hernández, N., & Rodriguez-Perez, J. M. (2021). Evaluation of leptin levels in serum as a biomarker for suicide behavior: Systematic review and meta-analysis. International Journal of Neuroscience, 131(1), 49–55. https://doi.org/10.1080/00207454.2020.1733558
Heeringen, K. van, & Mann, J. J. (2014). The neurobiology of suicide. The Lancet Psychiatry, 1(1), 63–72. https://doi.org/10.1016/S2215-0366(14)70220-2
Isung, J., Aeinehband, S., Mobarrez, F., Mårtensson, B., Nordström, P., Åsberg, M., Piehl, F., & Jokinen, J. (2012). Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Translational Psychiatry, 2(11), e196–e196. https://doi.org/10.1038/tp.2012.123
Kang, H.-J., Kim, J.-W., Kim, S.-W., Han, J.-S., Lyoo, I. K., & Kim, J.-M. (2023). Peripheral markers of suicidal behavior: Current findings and clinical implications. Clinical Psychopharmacology and Neuroscience, 21(4), 650–664. https://doi.org/10.9758/cpn.22.1046
Lindqvist, D., Janelidze, S., Erhardt, S., Träskman‐Bendz, L., Engström, G., & Brundin, L. (2011). CSF biomarkers in suicide attempters – A principal component analysis. Acta Psychiatrica Scandinavica, 124(1), 52–61. https://doi.org/10.1111/j.1600-0447.2010.01655.x
Lutz, P.-E., Mechawar, N., & Turecki, G. (2017). Neuropathology of suicide: Recent findings and future directions. Molecular Psychiatry, 22(10), 1395–1412. https://doi.org/10.1038/mp.2017.141
Mamdani, F., & Sequeira, A. (2022). Blood-based biomarkers for suicide in depression: Moving a step closer to prediction. Neuropsychopharmacology, 48(1), 245–246. https://doi.org/10.1038/s41386-022-01391-5
Mamun, M. A., Al-Mamun, F., Islam, J., & Muhit, M. (2022). Prevalence and associated factors of suicidal behaviors among Bangladeshi rural community people: Findings from the ‘BD ComMen Study.’ PLOS ONE, 17(12), e0279271. https://doi.org/10.1371/journal.pone.0279271
Neuroscience of suicidal ideation: Brain science and hope. (2026, January 12). https://mindlabneuroscience.com/neuroscience-of-suicidal-ideation/
News, N. (2024, March 14). Molecular alterations in brain tissue provide clues to suicidal ideation. https://neurosciencenews.com/genetics-brain-tissue-suicide-25761/
Pal, D. V. S., Bagul, D. K. R., Mudgal, V., Jain, P., & Dhakad, D. R. (n.d.). Is there an indicator for detecting suicidal behaviour even before it sets in?
Pandey, G. N. (2013). Biological basis of suicide and suicidal behavior. Bipolar Disorders, 15(5), 524–541. https://doi.org/10.1111/bdi.12089
Ren, N., Zheng, S., Zhou, Y., Zhang, X., Wang, M. H., & Bian, Y. (2026). The prospect of suicide biomarkers: From neurobiology to precision prevention. Frontiers in Psychology, 17, 1757838. https://doi.org/10.3389/fpsyg.2026.1757838
Sher, L. (2017). Commentary: CSF and plasma testosterone in attempted suicide. Frontiers in Public Health, 5, 92. https://doi.org/10.3389/fpubh.2017.00092
Sokolowski, M., Wasserman, J., & Wasserman, D. (2015). An overview of the neurobiology of suicidal behaviors as one meta-system. Molecular Psychiatry, 20(1), 56–71. https://doi.org/10.1038/mp.2014.101
Sonmez, D., Kurhan, F., & Hocaoglu, C. (2024). Neurobiology of suicide in depressive disorders (pp. 1–24). Springer, Cham. https://doi.org/10.1007/978-3-031-32035-4_152-1
The neurobiology of suicide: The “suicidal brain.” (n.d.). Retrieved September 20, 2026, from https://www.frontiersin.org/research-topics/31340/the-neurobiology-of-suicide-the-suicidal-brain/magazine
Turecki, G. (2014). The molecular bases of the suicidal brain. Nature Reviews Neuroscience, 15(12), 802–816. https://doi.org/10.1038/nrn3839
Walsh, R. F. L., Maddox, M. A., Smith, L. T., Liu, R. T., & Alloy, L. B. (2024). Social and circadian rhythm dysregulation and suicide: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 158, 105560. https://doi.org/10.1016/j.neubiorev.2024.105560
Zalsman, G. (2023). How else can inflammation kill you? European Neuropsychopharmacology, 67, 1–3. https://doi.org/10.1016/j.euroneuro.2022.11.003
Venous Congestion
Abdalkader, M., Nguyen, T. N., Norbash, A. M., Raz, E., Shapiro, M., Lenck, S., Brinjikji, W., Weber, P., & Sakai, O. (2021). State of the art: Venous causes of pulsatile tinnitus and diagnostic considerations guiding endovascular therapy. Radiology, 300(1), 2–16. https://doi.org/10.1148/radiol.2021202584
Adi, O., Fong, C. P., Azil, A., & Wahab, S. F. A. (2019). Fat embolism in right internal jugular vein: Incidental ultrasound finding during internal jugular vein cannulation. The Ultrasound Journal, 11(1), 1. https://doi.org/10.1186/s13089-019-0116-9
Ahn, S. S., Miller, T. J., Chen, J. F., Chen, S. W., Feldtman, R., & Hwang, W. (2013). Internal jugular vein stenosis in patients with thoracic outlet symptoms. Journal of Vascular Surgery, 57(5), 100S-101S. https://doi.org/10.1016/j.jvs.2013.02.234
Akbas, I., Gedik, B. S., Bisgin, E., & Guclu, O. (2025). Combined frontal cavernoma and developmental venous angioma presenting as organic personality disorder: A case report. BMC Psychiatry, 25(1), 1152. https://doi.org/10.1186/s12888-025-07596-4
Alkhamis, F., Alhajri, K., Aljaafari, D., Alhashim, A., Alsamarah, A., Sharydah, A., Basheir, O., AlSulaiman, F., & Alabdali, M. (2021). Recurrent facial palsy due to high jugular bulb dehiscence. Journal of Multidisciplinary Healthcare, Volume 14, 359–362. https://doi.org/10.2147/JMDH.S295950
Alperin, N., Lee, S. H., Mazda, M., Hushek, S. G., Roitberg, B., Goddwin, J., & Lichtor, T. (2005). Evidence for the importance of extracranial venous flow in patients with idiopathic intracranial hypertension (IIH). In W. S. Poon, M. T. V. Chan, K. Y. C. Goh, J. M.K. Lam, S. C. P. Ng, A. Marmarou, C. J. J. Avezaat, J. D. Pickard, M. Czosnyka, P. J. A. Hutchinson, & Y. Katayama (Eds.), Intracranial Pressure and Brain Monitoring XII (Vol. 95, pp. 129–132). Springer-Verlag. https://doi.org/10.1007/3-211-32318-X_28
Arif, T., & Gull, H. (2022). Anticoagulation in the treatment of pulsatile tinnitus caused by internal jugular vein stenosis: A rare case report. Journal of Medical Research and Surgery, 3(1), 10–12. https://doi.org/10.52916/jmrs224068
Arun, A., Amans, M. R., Higgins, N., Brinjikji, W., Sattur, M., Satti, S. R., Nakaji, P., Luciano, M., Huisman, T. A., Moghekar, A., Pereira, V. M., Meng, R., Fargen, K., & Hui, F. K. (2022). A proposed framework for cerebral venous congestion. The Neuroradiology Journal, 35(1), 94–111. https://doi.org/10.1177/19714009211029261
Aygun, N., Uludag, M., & Ozel, A. (2019). The clinical importance of tumor thrombus in internal jugular vein related to papillary thyroid cancer. Surgical Case Reports, 1–4. https://doi.org/10.31487/j.SCR.2019.04.06
Bai, C., Wang, Z., Guan, J., Jin, K., Ding, Y., Ji, X., & Meng, R. (2020). Clinical characteristics and neuroimaging findings in eagle syndrome induced internal jugular vein stenosis. Annals of Translational Medicine, 8(4), 97–97. https://doi.org/10.21037/atm.2019.12.93
Bai, C., Wang, Z., Stone, C., Zhou, D., Ding, J., Ding, Y., Ji, X., & Meng, R. (2021). Pathogenesis and management in cerebrovenous outflow disorders. Aging and Disease, 12(1), 203. https://doi.org/10.14336/AD.2020.0404
Bai, C., Xu, Y., Zhou, D., Ding, J., Yang, Q., Ding, Y., Ji, X., & Meng, R. (2019). The comparative analysis of non-thrombotic internal jugular vein stenosis and cerebral venous sinus stenosis. Journal of Thrombosis and Thrombolysis, 48(1), 61–67. https://doi.org/10.1007/s11239-019-01820-1
Bain, F. T. (n.d.). How to perform ultrasound evaluation of the jugular vein. DIAGNOSTIC IMAGING.
Barami, K. (2016). Cerebral venous overdrainage: An under-recognized complication of cerebrospinal fluid diversion. Neurosurgical Focus, 41(3), E9. https://doi.org/10.3171/2016.6.FOCUS16172
Beggs, C. B., Giaquinta, A., Veroux, M., De Marco, E., Mociskyte, D., & Veroux, P. (2018). Mid-term sustained relief from headaches after balloon angioplasty of the internal jugular veins in patients with multiple sclerosis. PLOS ONE, 13(1), e0191534. https://doi.org/10.1371/journal.pone.0191534
Beggs, C., Chung, C.-P., Bergsland, N., Wang, P.-N., Shepherd, S., Cheng, C.-Y., Dwyer, M. G., Hu, H.-H., & Zivadinov, R. (2013). Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer’s disease. BMC Neurology, 13(1), 157. https://doi.org/10.1186/1471-2377-13-157
Benson, J. (2026, September 23). September CSF masterclass on myelography. In September CSF masterclass on myelography. https://www.svin.org/i4a/pages/index.cfm?pageid=3767
Bettiol, A., Alibaz-Oner, F., Direskeneli, H., Hatemi, G., Saadoun, D., Seyahi, E., Prisco, D., & Emmi, G. (2023). Vascular Behcet syndrome: From pathogenesis to treatment. Nature Reviews Rheumatology, 19(2), 111–126. https://doi.org/10.1038/s41584-022-00880-7
Bragée, B., Michos, A., Drum, B., Fahlgren, M., Szulkin, R., & Bertilson, B. C. (2020). Signs of intracranial hypertension, hypermobility, and craniocervical obstructions in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in Neurology, 11, 828. https://doi.org/10.3389/fneur.2020.00828
Brinjikji, W., Madhavan, A., Garza, I., Whealy, M., Kissoon, N., Mark, I., Morris, P. P., Verdoorn, J., Benson, J. C., Atkinson, J. L. D., Kobeissi, H., & Cutsforth-Gregory, J. K. (2024). Clinical and imaging outcomes of 100 patients with cerebrospinal fluid-venous fistulas treated by transvenous embolization. Journal of NeuroInterventional Surgery, 16(12), 1256–1263. https://doi.org/10.1136/jnis-2023-021012
Buch, K., Groller, R., Nadgir, R. N., Fujita, A., Qureshi, M. M., & Sakai, O. (2016). Variability in the cross-sectional area and narrowing of the internal jugular vein in patients without multiple sclerosis. American Journal of Roentgenology, 206(5), 1082–1086. https://doi.org/10.2214/AJR.15.14689
Cappiello, J., Piazza, C., Berlucchi, M., Peretti, G., De Zinis, L., Maroldi, R., & Nicolai, P. (2002). Internal jugular vein patency after lateral neck dissection: A prospective study. European Archives of Oto-Rhino-Laryngology, 259(8), 409–412. https://doi.org/10.1007/s00405-002-0479-5
Cerebral venous outflow revisited: Contemporary insights to simplify a complex disease. (n.d.). https://doi.org/10.1177/15910199251380374
Chung, C.-P., & Hu, H.-H. (2008). Jugular venous reflux. Journal of Medical Ultrasound, 16(3), 210–222. https://doi.org/10.1016/S0929-6441(08)60050-8
Consoli, A., Cancelliere, N. M., Charbonnier, G., Nishi, H., Vanek, I., Marotta, T. R., Spears, J., & Pereira, V. M. (2025). Novel, braided, self-expandable stent designed for the treatment of pulsatile tinnitus caused by intracranial venous stenosis: First-in-human experience and long-term outcomes. Journal of NeuroInterventional Surgery, 17(5), 487–492. https://doi.org/10.1136/jnis-2024-021458
Coskunoglu, A., Orenay-Boyacioglu, S., Deveci, A., Bayam, M., Onur, E., Onan, A., & Cam, F. (2017). Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus. Noise and Health, 19(88), 140. https://doi.org/10.4103/nah.NAH_74_16
Dashti, S. R., Nakaji, P., Hu, Y. C., Frei, D. F., Abla, A. A., Yao, T., Fiorella, D., & Ogungbo, B. (2012). Styloidogenic jugular venous compression syndrome: Diagnosis and treatment: Case report. Neurosurgery, 70(3), 783–783. https://doi.org/10.1227/NEU.0b013e3182333859
Davis, B. M., Rantanen, P., Seo, G., Thadani, S., Spencer, E. B., Hepworth, E., & Cutchins, A. (2026). An overview of vascular compression syndromes and associations with autonomic dysfunction: A review. Biomedicines, 14(3), 689. https://doi.org/10.3390/biomedicines14030689
Department of Medical Imaging, Independent Public Province Hospital of J. Śniadecki in Białystok, Poland, Czyżewska, D., Krysiuk, K., Department of Radiology, The Medical University of Bialystok Clinical Hospital, Poland, Dobrzycki, K., Department of Invasive Cardiology, The Medical University of Bialystok Clinical Hospital, Poland, Ustymowicz, A., & Department of Radiology, The Medical University of Bialystok, Poland. (2015). Ultrasound assessment of the jugular and vertebral veins in healthy individuals: Selected physiological aspects and morphological parameters. Journal of Ultrasonography, 15(62), 267–273. https://doi.org/10.15557/JoU.2015.0023
Ding, J., Zhou, D., Pan, L., Ya, J., Liu, C., Yan, F., Fan, C., Ding, Y., Ji, X., & Meng, R. (2020). Cervical spondylotic internal jugular venous compression syndrome. CNS Neuroscience & Therapeutics, 26(1), 47–54. https://doi.org/10.1111/cns.13148
Eliav, T., Alguayn, F., Zlotnik, Y., & Horev, A. (2026). Cerebral Venous Insufficiency as a Contributing Factor in Dementia: An Emerging Hypothesis. Stroke: Vascular and Interventional Neurology, 6(1). https://doi.org/10.1161/SVIN.125.002083
Fargen, K. M. (2020). Idiopathic intracranial hypertension is not idiopathic: Proposal for a new nomenclature and patient classification. Journal of NeuroInterventional Surgery, 12(2), 110–114. https://doi.org/10.1136/neurintsurg-2019-015498
Fargen, K. M. (2021). A unifying theory explaining venous sinus stenosis and recurrent stenosis following venous sinus stenting in patients with idiopathic intracranial hypertension. Journal of NeuroInterventional Surgery, 13(7), 587–592. https://doi.org/10.1136/neurintsurg-2020-017208
Fargen, K. M. (2022). Venous stenting for idiopathic intracranial hypertension: Lessons learned from a high-volume practice. Journal of NeuroInterventional Surgery, 14(6), 528–532. https://doi.org/10.1136/neurintsurg-2021-018184
Fargen, K. M., Amans, M. R., & Hui, F. K. (2025). The Cerebral Venous Disorders Severity Scale. Journal of NeuroInterventional
Surgery, 17(2), 115–116. https://doi.org/10.1136/jnis-2024-022976
Fargen, K. M., Ashraf, O., Suri, A. E., Margraf, C., Amans, M. R., Tateshima, S., Zhang, Y. J., & Hui, F. K. (2026). Straight sinus stenosis: Prevalence in cerebral venous disorders and the role of stenting. Journal of NeuroInterventional Surgery, 18(6), 1558–1563. https://doi.org/10.1136/jnis-2025-023942
Fargen, K. M., Garner, R. M., Kittel, C., & Wolfe, S. Q. (2020). A descriptive study of venous sinus pressures and gradients in patients with idiopathic intracranial hypertension. Journal of NeuroInterventional Surgery, 12(3), 320–325. https://doi.org/10.1136/neurintsurg-2019-015251
Fargen, K. M., Hui, F., & Hirsch, J. A. (2023). Cerebral venous disorders: The path forward. Journal of NeuroInterventional Surgery, 15(4), 309–309. https://doi.org/10.1136/jnis-2023-020251
Fargen, K. M., Kittel, C., Amans, M. R., Brinjikji, W., & Hui, F. (2023). A national survey of venous sinus stenting practices for idiopathic intracranial hypertension. Journal of NeuroInterventional Surgery, 15(5), 507–511. https://doi.org/10.1136/neurintsurg-2022-018832
Fargen, K. M., Midtlien, J. P., Margraf, C. R., Wiater, A. H., Marcet, P. A., Siddiqui, A. H., & Hui, F. (2025). Cerebral venous pressures, sinus trans-stenosis gradients, and intracranial pressures are dramatically augmented by head position. Journal of NeuroInterventional Surgery, 17(10), 1120–1126. https://doi.org/10.1136/jnis-2024-022167
Fargen, K. M., Velat, G. J., Lewis, S. B., Hoh, B. L., Mocco, J., & Lawson, M. F. (2013). Concomitant intracranial pressure monitoring during venous sinus stenting for intracranial hypertension secondary to venous sinus stenosis. Journal of NeuroInterventional Surgery, 5(4), e22–e22. https://doi.org/10.1136/neurintsurg-2012-010371
Flounders, J. A. (2003). Superior vena cava syndrome. Oncology Nursing Forum, 30(4), E84–E90. https://doi.org/10.1188/03.ONF.E84-E90
Fritch, C., Voronovich, Z., & Carlson, A. P. (2020). C1 transverse process resection for management of jugular stenosis. Operative Neurosurgery, 19(2), E209–E213. https://doi.org/10.1093/ons/opaa032
Frommer, J. (1974). Anatomic variations in the stylohyoid chain and their possible clinical significance. Oral Surgery, Oral Medicine, Oral Pathology, 38(5), 659–667. https://doi.org/10.1016/0030-4220(74)90382-X
Fulop, G. A., Ahire, C., Csipo, T., Tarantini, S., Kiss, T., Balasubramanian, P., Yabluchanskiy, A., Farkas, E., Toth, A., Nyúl-Tóth, Á., Toth, P., Csiszar, A., & Ungvari, Z. (2019). Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice. GeroScience, 41(5), 575–589. https://doi.org/10.1007/s11357-019-00110-1
Gorton, A. J., Nandavaram, S., & Keshavamurthy, S. (2023). (1087) cerebral venous congestion in patient with oxyrvad V-V ecmo presenting as blurred vision. The Journal of Heart and Lung Transplantation, 42(4), S468–S469. https://doi.org/10.1016/j.healun.2023.02.1298
Grech, O., Clouter, A., Mitchell, J. L., Alimajstorovic, Z., Ottridge, R. S., Yiangou, A., Roque, M., Tahrani, A. A., Nicholls, M., Taylor, A. E., Shaheen, F., Arlt, W., Lavery, G. G., Shapiro, K., Mollan, S. P., & Sinclair, A. J. (2021). Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure. Brain Communications, 3(3), fcab202. https://doi.org/10.1093/braincomms/fcab202
Gweon, H. M., Chung, T.-S., & Suh, S. H. (2011). Evaluation of the cause of internal jugular vein obstruction on head and neck contrast enhanced 3D MR angiography using contrast enhanced computed tomography. Journal of the Korean Society of Magnetic Resonance in Medicine, 15(1), 41. https://doi.org/10.13104/jksmrm.2011.15.1.41
Hagens, M. H. J., Hoogervorst, E. L. J., Frequin, S. T. F. M., & Tromp, S. C. (2013). Cerebrospinal venous outflow in multiple sclerosis patients versus fatigue and/or depression. Interventional Neurology, 2(4), 193–200. https://doi.org/10.1159/000363070
Hammed, A., Richter, G., Ismail, O., Niemöller, U., & Tanislav, C. (2025). C25 Jugular eagle syndrome as a rare cause of cerebral venous sinus thrombosis: A case report and treatment considerations. 4. Cerebral Venous Disorders – 4.1 Cerebral Venous Sinus Thrombosis, A151–A152. https://doi.org/10.1136/jnis-2025-ESMINT.217
Hashemizad, A., Dela Cruz, J., Narayan, A., & Maxwell, A. J. (2025). Hyperventilation during rest and exercise in orthostatic intolerance and Spiky-Leaky Syndrome. Frontiers in Neurology, 16, 1512671. https://doi.org/10.3389/fneur.2025.1512671
Hepworth, E. J., Love, A. V., & Hartford, R. L. (2021). Intracranial hypertension secondary to venous outflow obstruction. Journal of Neurological Surgery Part B: Skull Base, 82(S 02), OD068. https://doi.org/10.1055/s-0041-1725347
Higgins, J., Garnett, M., Pickard, J., & Axon, P. (2016). An evaluation of styloidectomy as an adjunct or alternative to jugular stenting in idiopathic intracranial hypertension and disturbances of cranial venous outflow. Journal of Neurological Surgery Part B: Skull Base, 78(02), 158–163. https://doi.org/10.1055/s-0036-1594238
Higgins, J. N., Axon, P. R., & Macfarlane, R. (2020). Spontaneous intracranial hypotension complicated by subdural effusions treated by surgical relief of cranial venous outflow obstruction. Journal of Neurological Surgery Reports, 81(04), e59–e65. https://doi.org/10.1055/s-0040-1722268
Higgins, J. N. P., Axon, P. R., & Lever, A. M. L. (2023). Life changing response to successive surgical interventions on cranial venous outflow: A case report on chronic fatigue syndrome. Frontiers in Neurology, 14, 1127702. https://doi.org/10.3389/fneur.2023.1127702
Higgins, J. N. P., & Kirker, S. (2023). Case report: Post-traumatic Tourette syndrome resolving with treatment of jugular venous narrowing; reconciling organic brain dysfunction following whiplash trauma with the absence of direct brain injury. Frontiers in Neurology, 14, 1179596. https://doi.org/10.3389/fneur.2023.1179596
Higgins, N., Pickard, J., & Lever, A. (2015). Borderline intracranial hypertension manifesting as chronic fatigue syndrome treated by venous sinus stenting. Journal of Neurological Surgery Reports, 76(02), e244–e247. https://doi.org/10.1055/s-0035-1564060
Higgins, N., Trivedi, R., Greenwood, R., & Pickard, J. (2015). Brain slump caused by jugular venous stenoses treated by stenting: A hypothesis to link spontaneous intracranial hypotension with idiopathic intracranial hypertension. Journal of Neurological Surgery Reports, 76(01), e188–e193. https://doi.org/10.1055/s-0035-1555015
Hlubek, R., Yashar, M., Kalani, S., Levitt, M., Albuquerque, F., & Nakaji, P. (2016). Microsurgical treatment of styloidogenic jugular venous compression syndrome. Journal of Neurological Surgery Part B: Skull Base, 77(S 01), s-0036-1579950. https://doi.org/10.1055/s-0036-1579950
Ho, S., Luginbuhl, A., Finden, S., Curry, J. M., & Cognetti, D. M. (2015). Styloid/C1 transverse process juxtaposition as a cause of eagle’s syndrome: Possible cause of eagle’s syndrome. Head & Neck, 37(11), E153–E156. https://doi.org/10.1002/hed.24024
Hyer, S. L., Dandekar, P., Newbold, K., Haq, M., Wechalakar, K., & Harmer, C. (2008). Thyroid cancer causing obstruction of the great veins in the neck. World Journal of Surgical Oncology, 6(1), 36. https://doi.org/10.1186/1477-7819-6-36
Inam, M. E., Martinez-Gutierrez, J. C., Kole, M. J., Sanchez, F., Lekka, E., Truong, V. T. T., Lopez-Rivera, V., Sheriff, F. G., Zima, L. A., Pedroza, C., Tang, R., Adesina, O.-O., Engstrom, A., Sheth, S. A., & Chen, P. R. (2022). Venous sinus stenting for low pressure gradient stenoses in idiopathic intracranial hypertension. Neurosurgery, 91(5), 734–740. https://doi.org/10.1227/neu.0000000000002095
Inci, S., Bertan, V., Kansu, T., & Cila, A. (1995). Horner’s syndrome due to jugular venous ectasia. Child’s Nervous System, 11(9), 533–535. https://doi.org/10.1007/BF00822844
Iyer, A. M., Midtlien, J. P., Kittel, C., Klever, L. A., Wiater, A., Chang, E., Margraf, C., & Fargen, K. M. (2025). The correlation between intracranial pressure and venous sinus pressures changes after venous sinus stenting. Journal of NeuroInterventional Surgery, 17(12), 1347–1353. https://doi.org/10.1136/jnis-2024-022250
Jayaraman, M. V., Boxerman, J. L., Davis, L. M., Haas, R. A., & Rogg, J. M. (2012). Incidence of extrinsic compression of the internal jugular vein in unselected patients undergoing CT angiography. American Journal of Neuroradiology, 33(7), 1247–1250. https://doi.org/10.3174/ajnr.A2953
Jost, G. F., & Dailey, A. T. (2015). Bow hunter’s syndrome revisited: 2 new cases and literature review of 124 cases. Neurosurgical Focus, 38(4), E7. https://doi.org/10.3171/2015.1.FOCUS14791
Kee, T. P., & Krings, T. (2026). Glymphatics in neurovascular diseases. Journal of NeuroInterventional Surgery, 18(5), 1428–1434. https://doi.org/10.1136/jnis-2025-023713
Kinsara, R., Kapadia, A., & Meng, H. (2026). Is headache always necessary for the diagnosis of rebound intracranial hypertension in patients successfully treated for cerebrospinal fluid venous fistula? Headache: The Journal of Head and Face Pain, 66(6), 1386–1389. https://doi.org/10.1111/head.70088
Kostecki, J., & Zaniewski, M. (2016). The hemodynamics of blood flow through the internal jugular veins after CCSVI endovascular treatment and its impact on the quality of life in patients with chronic cerebrospinal venous insufficiency. Brain Disorders & Therapy, 05(03). https://doi.org/10.4172/2168-975X.1000219
Kosugi, K., Yamada, Y., Yamada, M., Yokoyama, Y., Fujiwara, H., Yoshida, K., Yoshida, K., Toda, M., & Jinzaki, M. (2020). Posture-induced changes in the vessels of the head and neck: Evaluation using conventional supine CT and upright CT. Scientific Reports, 10(1), 16623. https://doi.org/10.1038/s41598-020-73658-0
Kuhn, A., Singh, J., Massari, F., & Puri, A. (2022). E-117 Demographics, imaging findings, and diagnosis in patients with (post)coital headaches. SNIS 19th Annual Meeting Electronic Poster Abstracts, A140.1-A140. https://doi.org/10.1136/neurintsurg-2022-SNIS.228
Lan, D., Song, S., Jia, M., Wang, M., Jiao, B., Liu, Y., Ding, Y., Ji, X., & Meng, R. (2022). Cerebral venous-associated brain damage may lead to anxiety and depression. Journal of Clinical Medicine, 11(23), 6927. https://doi.org/10.3390/jcm11236927
Larsen, K. (n.d.). Jugular outlet syndrome (JOS), a common sequela of chronic upper cervical dysfunction.
Li, M., Gao, X., Rajah, G. B., Liang, J., Chen, J., Yan, F., Bao, Y., Jiao, L., Zhang, H., Ding, Y., Ji, X., & Meng, R. (2019). Styloidectomy and venous stenting for treatment of styloid-induced internal jugular vein stenosis: A case report and literature review. World Neurosurgery, 130, 129–132. https://doi.org/10.1016/j.wneu.2019.06.100
Li, M., Sun, Y., Chan, C. C., Fan, C., Ji, X., & Meng, R. (2019). Internal jugular vein stenosis associated with elongated styloid process: Five case reports and literature review. BMC Neurology, 19(1), 112. https://doi.org/10.1186/s12883-019-1344-0
Longley, D. G., Finlay, D. E., & Letourneau, J. G. (1993). Sonography of the upper extremity and jugular veins. American Journal of Roentgenology, 160(5), 957–962. https://doi.org/10.2214/ajr.160.5.8470610
Malagoni, A. M., Galeotti, R., Menegatti, E., Manfredini, F., Basaglia, N., Salvi, F., & Zamboni, P. (n.d.). Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis? A longitudinal pilot study.
Margraf, C. R., Hui, F. K., Midtlien, J. P., Wiater, A. H., Kittel, C. A., Ehrig, M. R., Hirshman, A. P., Siddiqui, A. H., & Fargen, K. M. (2026). Intracranial pressure is affected by head rotation: Effect of dynamic jugular stenosis on lumbar puncture opening pressure. Journal of NeuroInterventional Surgery, 18(4), 1170–1175. https://doi.org/10.1136/jnis-2025-023516
Marina, N., Christie, I. N., Korsak, A., Doronin, M., Brazhe, A., Hosford, P. S., Wells, J. A., Sheikhbahaei, S., Humoud, I., Paton, J. F. R., Lythgoe, M. F., Semyanov, A., Kasparov, S., & Gourine, A. V. (2020). Astrocytes monitor cerebral perfusion and control systemic circulation to maintain brain blood flow. Nature Communications, 11(1), 131. https://doi.org/10.1038/s41467-019-13956-
Maurer, R. (2020). Intracranial venous sinus stenting improves headaches and cognitive dysfunction associated with ehlers-danlos syndrome type III. Biomedical Journal of Scientific & Technical Research, 26(4). https://doi.org/10.26717/BJSTR.2020.26.004374
Maxwell, A. J., & Wardly, D. (2024). The complex path to intracranial hypertension and CSF leak in those with hypermobility and dysautonomia; the theory of spiky-leaky syndrome. MAR Pediatrics, 05(03), 86.
Midtlien, J. P., Curry, B. P., Chang, E., Kiritsis, N. R., Aldridge, J. B., & Fargen, K. M. (2024). Characterizing a new clinical phenotype: The co-existence of cerebral venous outflow and connective tissue disorders. Frontiers in Neurology, 14, 1305972. https://doi.org/10.3389/fneur.2023.1305972
Miyamoto, S., Hidaka, T., Fukuoka, O., Fujisawa, K., & Okazaki, M. (2023). Internal jugular vein reconstruction using a triple-paneled great saphenous vein graft. World Journal of Surgical Oncology, 21(1), 10. https://doi.org/10.1186/s12957-023-02902-4
Mohammed, N. Y., Di Domenico, G., & Gambaccini, M. (2019). Cerebral venous drainage through internal jugular vein. Veins and Lymphatics, 8(3). https://doi.org/10.4081/vl.2019.8379
Monagle, P., Cuello, C. A., Augustine, C., Bonduel, M., Brandao, L. R., Capman, T., Chan, A. K. C., Hanson, S., Male, C., Meerpohl, J., Newall, F., O’Brien, S. H., Raffini, L., van Ommen, H., Wiernikowski, J., Williams, S., Bhatt, M., Riva, J. J., Roldan, Y., … Vesely, S. K. (2018). American Society of Hematology 2018 Guidelines for management of venous thromboembolism: Treatment of pediatric venous thromboembolism. Blood Advances, 2(22), 3292–3316. https://doi.org/10.1182/bloodadvances.2018024786
Nicholson, P., Brinjikji, W., Radovanovic, I., Hilditch, C. A., Tsang, A. C. O., Krings, T., Mendes Pereira, V., & Lenck, S. (2019). Venous sinus stenting for idiopathic intracranial hypertension: A systematic review and meta-analysis. Journal of NeuroInterventional Surgery, 11(4), 380–385. https://doi.org/10.1136/neurintsurg-2018-014172
Objective measurements of IJV compression at C1. (n.d.).
P. Higgins, J. N., & Pickard, J. D. (2021). A paradigm for chronic fatigue syndrome: Caught between idiopathic intracranial hypertension and spontaneous intracranial hypotension; caused by cranial venous outflow obstruction. Fatigue: Biomedicine, Health & Behavior, 9(3), 139–147. https://doi.org/10.1080/21641846.2021.1956223
Pang, S., Kolarich, A. R., Brinjikji, W., Nakaji, P., Hepworth, E., & Hui, F. (2022). Interventional and surgical management of internal jugular venous stenosis: A narrative review. Journal of NeuroInterventional Surgery, 14(5), 503–507. https://doi.org/10.1136/neurintsurg-2021-017937
Permpalung, N., Suksaranjit, P., Chongnarungsin, D., & Hyman, C. (2014). Unveiling the hidden eagle: Acute parotitis-induced eagle syndrome. North American Journal of Medical Sciences, 6(2), 102. https://doi.org/10.4103/1947-2714.127753
Pescarini, E., Butler, D. P., Perusseau-Lambert, A., Nduka, C., & Kannan, R. Y. (2021). Targeted chemodenervation of the posterior belly of the digastric muscle for the management of jaw discomfort in facial synkinesis. Journal of Plastic, Reconstructive & Aesthetic Surgery, 74(12), 3437–3442. https://doi.org/10.1016/j.bjps.2021.05.045
Pokeerbux, M. R., Delmaire, C., Morell-dubois, S., Demondion, X., & Lambert, M. (2020). Styloidogenic compression of the internal jugular vein, a new venous entrapment syndrome? Vascular Medicine, 25(4), 378–380. https://doi.org/10.1177/1358863X20902842
Primiani, C. T., Lawton, M., Hillis, A. E., & Hui, F. K. (2022). Pearls & oy-sters: Cerebral venous congestion associated with cognitive decline treated by jugular release. Neurology, 99(13), 577–580. https://doi.org/10.1212/WNL.0000000000201037
Samaniego, E. A., Abrams, K. J., Dabus, G., Starr, R., & Linfante, I. (2013). Severe venous congestive encephalopathy secondary to a dialysis arteriovenous graft. Journal of NeuroInterventional Surgery, 5(5), e37–e37. https://doi.org/10.1136/neurintsurg-2012-010355
Sankala, H. A., & Hashim, H. (2021). Intracranial calcification in venous congestion. Egyptian Journal of Radiology and Nuclear Medicine, 52(1), 181. https://doi.org/10.1186/s43055-021-00564-4
Saposnik, G., Bushnell, C., Coutinho, J. M., Field, T. S., Furie, K. L., Galadanci, N., Kam, W., Kirkham, F. C., McNair, N. D., Singhal, A. B., Thijs, V., & Yang, V. X. D. (2024). Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association. Stroke, 55(3), E77–E90. https://doi.org/10.1161/STR.0000000000000456
Scerrati, A., Norri, N., Mongardi, L., Dones, F., Ricciardi, L., Trevisi, G., Menegatti, E., Zamboni, P., Cavallo, M. A., & De Bonis, P. (2021). Styloidogenic-cervical spondylotic internal jugular venous compression, a vascular disease related to several clinical neurological manifestations: Diagnosis and treatment—a comprehensive literature review. Annals of Translational Medicine, 9(8), 718–718. https://doi.org/10.21037/atm-20-7698
Schartz, D., Finkelstein, A., Akkipeddi, S. M. K., Kessler, A., Williams, Z., Vates, E., Hauck, E. F., Fargen, K. M., & Bender, M. T. (2025). Total brain volume is associated with severity of transverse sinus stenosis in idiopathic intracranial hypertension. Journal of NeuroInterventional Surgery, 17(7), 764–768. https://doi.org/10.1136/jnis-2024-021938
Seoane, E., & Rhoton, A. L. (1999). Compression of the internal jugular vein by the transverse process of the atlas as the cause of cerebellar hemorrhage after supratentorial craniotomy. Surgical Neurology, 51(5), 500–505. https://doi.org/10.1016/S0090-3019(97)00476-X
Simka, M., Latacz, P., & Redelbach, W. (2020). Cerebral venous outflow in the prone position. Child’s Nervous System, 36(1), 11–12. https://doi.org/10.1007/s00381-019-04321-x
Society of Vascular and Interventional Neurology. (2026, September 23). CSF masterclass: A monthly online course by the
Society of Vascular and Interventional Neurology. CSF Masterclass: A Monthly Online Course by the Society of Vascular and Interventional Neurology. https://www.svin.org/i4a/pages/index.cfm?pageid=3767
Sørensen, H. T., Darvalics, B., Horváth-Puhó, E., Hjorth, C. F., Sundbøll, J., & Bøtker, H. E. (2026). Venous thromboembolism and suicide: A Danish nationwide case-control study. Journal of Thrombosis and Haemostasis, 0(0). https://doi.org/10.1016/j.jtha.2026.09.016
Spagnolo, S. (2018). The role of chronic superior caval syndrome and stenosis of jugular veins in neurodegenerative diseases. Surgical treatment and preliminary results. Journal of Clinical & Experimental Cardiology, 09. https://doi.org/10.4172/2155-9880-C5-100
Spagnolo, S., Barbato, L., Grasso, M. A., Bavera, P. M., Carroz Zo, A., Vardanyan, R., Rad, A. A., & Spagnolo, P. (2020). The chronic stenosis of the internal jugular veins as a cause of multiple sclerosis. Journal of Cardiology Research Review & Reports, 1(1), 1. https://doi.org/10.47363/JCRRR/2020(1)106
Spencer, E. B., Elhage Hassan, M., Saikia, J., Ajeya, D., Phillips, R., Steinberg, R. S., Abojaib, L., Bortfeld, K., Thadani, S., Bernstein, A., McGeoch, C., Davis, B., Garcia, M., Almuwaqqat, Z., Gilliland, C., & Cutchins, A. (2026). Association and post-iliac vein stenting symptom improvement of postural orthostatic tachycardia syndrome and orthostatic intolerance with pelvic venous disorders: Two retrospective studies. eClinicalMedicine, 92, 103772. https://doi.org/10.1016/j.eclinm.2026.103772
Suri, A. E., Torigoe, T. H., Young, C. M., Johnson, M., & Hepworth, E. J. (2026). Venous outflow and quality of life improvement after styloidectomy and jugular venous decompression. Neurosurgical Focus, 60(1), E19. https://doi.org/10.3171/2025.10.FOCUS25844
The Promise, Mystery, and Perils of Stenting for...: Neurosurgery. (n.d.). Ovid. https://doi.org/10.1227/neu.0000000000002891
Townsend, R. K., Jost, A., Amans, M. R., Hui, F., Bender, M. T., Satti, S. R., Maurer, R., Liu, K., Brinjikji, W., & Fargen, K. M. (2022). Major complications of dural venous sinus stenting for idiopathic intracranial hypertension: Case series and management considerations. Journal of NeuroInterventional Surgery, 14(1), neurintsurg-2021-017361. https://doi.org/10.1136/neurintsurg-2021-017361
Tschoe, C., Garner, R. M., Kittel, C., Traunero, J. R., Wolfe, S. Q., & Fargen, K. M. (2020). Changes in mean arterial pressure and end-tidal carbon dioxide content affect venous sinus pressures in patients with idiopathic intracranial hypertension: A randomized study. Journal of NeuroInterventional Surgery, 12(9), 906–910. https://doi.org/10.1136/neurintsurg-2019-015741
Waldock, W. J., Higgins, N. J., & Axon, P. (2020). A case report of gastroparesis resolved by styloidectomy. Otolaryngology Case Reports, 16, 100201. https://doi.org/10.1016/j.xocr.2020.100201
Wang, M., Wu, X., Lan, D., Zhou, D., Ding, Y., Ji, X., & Meng, R. (2022). Differentiation between anatomical slenderness and acquired stenosis of the internal jugular veins. CNS Neuroscience & Therapeutics, 28(11), 1849–1860. https://doi.org/10.1111/cns.13924
Wang, Z., Ding, J., Bai, C., Ding, Y., Ji, X., & Meng, R. (2020). Clinical classification and collateral circulation in chronic cerebrospinal venous insufficiency. Frontiers in Neurology, 11, 913. https://doi.org/10.3389/fneur.2020.00913
Wei, H., Jiang, H., Zhou, Y., Xiao, X., Zhou, C., & Ji, X. (2023). Cerebral venous congestion alters brain metabolite profiles, impairing cognitive function. Journal of Cerebral Blood Flow & Metabolism, 43(11), 1857–1872. https://doi.org/10.1177/0271678X231182244
West, J. L., Greeneway, G. P., Garner, R. M., Aschenbrenner, C. A., Singh, J., Wolfe, S. Q., & Fargen, K. M. (2019). Correlation between angiographic stenosis and physiologic venous sinus outflow obstruction in idiopathic intracranial hypertension. Journal of NeuroInterventional Surgery, 11(1), 90–94. https://doi.org/10.1136/neurintsurg-2018-014004
Westbrook, A. M., Kabbaz, V. J., & Showalter, C. R. (2020). Eagle’s syndrome, elongated styloid process and new evidence for pre-manipulative precautions for potential cervical arterial dysfunction. Musculoskeletal Science and Practice, 50, 102219. https://doi.org/10.1016/j.msksp.2020.102219
Wu, X., Ding, Y., Ji, X., & Meng, R. (2022). Jugular foramen and venous collaterals may help to discriminate congenital from post-thrombotic jugular stenosis. European Journal of Medical Research, 27(1), 10. https://doi.org/10.1186/s40001-022-00636-9
Yang, Y., Jia, H., & Liu, H. (2026). Cerebrospinal fluid dynamics and brain function regulation: From homeostasis to neurological disorders. Frontiers in Neuroscience, 20. https://doi.org/10.3389/fnins.2026.1775240
Yeoh, T. Y., Venkatraghavan, L., Fisher, J. A., & Meineri, M. (2017). Internal jugular vein blood flow in the upright position during external compression and increased central venous pressure: An ultrasound study in healthy volunteers. Canadian Journal of Anesthesia/Journal Canadien d’anesthésie, 64(8), 854–859. https://doi.org/10.1007/s12630-017-0903-3
Zamboni, P., Scerrati, A., Menegatti, E., Galeotti, R., Lapparelli, M., Traina, L., Tessari, M., Ciorba, A., De Bonis, P., & Pelucchi, S. (2019). The eagle jugular syndrome. BMC Neurology, 19(1), 333. https://doi.org/10.1186/s12883-019-1572-3
Zaniewski, M., & Simka, M. (2012). Biophysics of venous return from the brain from the perspective of the pathophysiology of chronic cerebrospinal venous insufficiency. Reviews on Recent Clinical Trials, 7(2), 88–92. https://doi.org/10.2174/157488712800100288
Zeng, X., Wang, Y., & Liu, L. (2025). Novel insights into the pathophysiology of idiopathic intracranial hypertension: A commentary on brain volume and transverse sinus stenosis. Journal of NeuroInterventional Surgery, 17(6), e8–e8. https://doi.org/10.1136/jnis-2024-022817
Zhao, X., Cavallo, C., Hlubek, R. J., Mooney, M. A., Belykh, E., Gandhi, S., Moreira, L. B., Lei, T., Albuquerque, F. C., Preul, M. C., & Nakaji, P. (2019). Styloidogenic jugular venous compression syndrome: Clinical features and case series. Operative Neurosurgery, 17(6), 554–561. https://doi.org/10.1093/ons/opz012
Zhou, D., Ding, J., Ya, J., Pan, L., Yan, F., Yang, Q., Ding, Y., Ji, X., & Meng, R. (2018). Understanding jugular venous outflow disturbance. CNS Neuroscience & Therapeutics, 24(6), 473–482. https://doi.org/10.1111/cns.12859
Zhou, D., Meng, R., Zhang, X., Guo, L., Li, S., Wu, W., Duan, J., Song, H., Ding, Y., & Ji, X. (2018). Intracranial hypertension induced by internal jugular vein stenosis can be resolved by stenting. European Journal of Neurology, 25(2), 365. https://doi.org/10.1111/ene.13512
Zivadinov, R., & Chung, C.-P. (2013). Potential involvement of the extracranial venous system in central nervous system disorders and aging. BMC Medicine, 11(1), 260. https://doi.org/10.1186/1741-7015-11-260
"We walk with you."
~Our Neuro Network
Contact
Subscribe to newsletter
E-mail: connect@ourneuronetwork.org
Telehealth Phone: 808-295-4021
Telehealth Fax: 808-666-9212
Coaching and Consulting Phone: 307-335-4968
Coaching and Consulting Fax: 307-312-3277
Medical and Legal Disclaimer: The information provided on this website is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Do not disregard or delay seeking medical care because of content you have read here.
Always consult your licensed healthcare provider or qualified medical team before making any healthcare decisions, starting or stopping medications, or implementing any lifestyle, nutritional, or therapeutic interventions.
Use of this site and its content is at your own discretion and risk. No patient-provider relationship is established by viewing or interacting with this website or its associated social media, podcasts, or communications. If you are experiencing a medical emergency, call 911 or go to your nearest emergency department.
While every effort is made to ensure accuracy and currency, Our Neuro Network and its affiliates make no representations or warranties of any kind, express or implied, regarding completeness, accuracy, reliability, suitability, or availability of any information, products, or services mentioned herein.
By using this website, you agree that Our Neuro Network, its owner(s), affiliates, and representatives are not liable for any direct or indirect damages or consequences arising from your use of this content.
© 2025 Our Neuro Network | All Rights Reserved | Privacy Policy | Terms of Use
HONOR. HOMEOSTASIS. HOPE.
